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The design and synthesis of a new bi-functional fluorophore with emission 
and excitation wavelengths similar to fluorescein, and the utility of the fluorophore in 
microarray and bioimaging applications are described herein. We demonstrate the 
compatilibity of the fluorophore to solid-phase peptide synthesis for the assembly of 
various fluorophore-peptide conjugates which are used fluorogenic substrates for 
detecting protease activity on the microarray and in live cells. With the objective of 
expanding the bioimaging applications of the fluorophore to detecting protease 
activity in specific organelles, we synthesized, via solid phase synthesis, peptide 
conjugates functionalized with an alkyne which can be attached to cellular 
localization sequences via “click chemistry”. The use of a single fluorophore for these 
applications obviates the need for re-designing and synthetic evaluation of peptide 
conjugates for potetntial substrate profiling on the microarray and the live-cell 
imaging of enzyme activity separately. 
 
Based on the scaffold of our new fluorophore, we designed and synthesized a 
panel of new fluorophores with emission wavelengths from blue to yellow region by 
the “click” reaction of alkyne-functionalized xanthones and xanthenes with various 
azides. Screening of these fluorophores led to the identification of “hit” fluorophores 
which showed a fluorescence increase upon triazole formation. These “click”-





CHAPTER 1 INTRODUCTION 
 
1.1 Detecting Enzyme Activity 
 
Enzymes – macromolecular catalysts in biological reactions – are the life force 
of the cell, providing it with energy and function. Numerous pathological conditions 
are caused by aberrant enzymatic activity, leading researchers to seek the “magic 
bullet” for the specific inhibition or activation for each disease-associated enzyme [1]. 
These enzymes constitute more than twenty percent of the drug targets [2], 
underscoring the importance of finding small molecule modulators with either the aim 
of gaining a fundamental understanding of enzyme function or with the ultimate 
purpose of drug discovery. The development of enabling tools that could 
quantitatively assess the efficacy of these modulators in a reliable fashion is thus of 
tantamount importance. In vitro assays for various classes of enzymes have evolved 
from the labor-intensive, use of liquid chromatography and radio-labeled enzyme 
substrates to operationally simple methods allowing high-throughput and image-based 
analysis. In vivo tracking of enzymatic activity has advanced rapidly from the 
landmark discovery and applications of the green fluorescent protein (GFP), a 
milestone development in molecular biology that was awarded the Nobel Prize in 
2008. 
 
 Assays employing fluorescence detection methods have seen widespread use 
in both the academics and the industry. The appeal of fluorescence methods stems 
from their compatibility in both in vivo and in vitro settings, as well as their suitability 
for both quantitative analyses for real-time monitoring of enzyme kinetics and for 
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visual tracking of enzymatic activity. The proven utility of these assays has driven 
active research in designing and/or modifying fluorescent proteins, inorganic 
nanoparticles and small molecule organic fluorophores for use in these assays. 
Enzyme assays with fluorescence-based detection methods are based on a common 
principle – the synthetic substrate containing a fluorophore or pro-fluorophore is acted 
upon by the enzyme which results in a significant change in the fluorescence property 
of the substrate. This change could be achieved with the following mechanisms: 1) 
fluorescence resonance energy transfer (FRET) between a donor and acceptor 
fluorophore and other fluorophore-fluorophore interactions leading to quenching; 2) a 
fluorogenic dye which displays no or low fluorescence until enzymatic action on the 
substrate; and 3) the use of a metal sensitive-fluorogenic dye which is fluorescent 
only when chelated to metals, or an environment-sensitive fluorophore which display 
different spectral properties in different media (Figure 1.1). A formidable arsenal of 
organic fluorophores that display fluorescence changes through these mechanisms has 
been developed.  Coupled with their amenability to structural changes through 
chemical synthesis, organic fluorophores now constitute an important component of 
the fluorescent toolbox. Their versatility has led to the development of synthetic 
substrates for enzymes that are not readily assayed using genetically encoded 
biosensors assembled from fluorescent proteins. The following section surveys the 













Figure 1.1. Enzyme assays with fluorescence detection methods. a) In FRET substrates, 
fluorescence emission is observed from the acceptor fluorophore (red) when excited at the 
donor excitation wavelength until enzymatic cleavage of the substrate separates the donor 
and acceptor. Thereafter, emission is observed at the donor emission wavelength. b) the 
fluorogenic substrate is not fluorescent with the enzyme recognition head is attached. Upon 
enzymatic cleavage which removes the recognition head, fluorescence is restored. c) Addition 
of a phosphate group to the substrate by a kinase allows chelation of a metal ion by the 










1.2 Small Molecule-Based Fluorogenic Enzyme Substrates 
 
1.2.1 FRET and internally quenched substrates 
 
These fluorogenic substrates have fluorophores that are quenched by the 
interaction with an adjacent fluorophore or a fluorescently silent acceptor. While both 
types of interactions result in the decrease of the parent fluorophore, quenching and 
fluorescence resonance energy transfer are mechanistically distinct [4]. Quenching 
arises from the interaction of the electron cloud of the fluorophore and the quencher, 
and since molecular contact falls off rapidly with distance, most quenching 
mechanisms are operative only at short distances.  This phenomenon was utilized in 
the design of synthetic graft polymers for selective tumor imaging by the Weissleder 
group [5]. The polymer consists of poly-L-lysine, which contains Cy5.5 (a near-
infrared cyanine dye) conjugated to some of the lysine residues, with the remaining 
residues either bearing free amines or protected with methoxypolyethylene glycol. In 
the intact polymer, the cyanine dyes are held in close proximity relative to each other 
and are quenched. The biocompatible polymer is known to accumulate in tumor cells 
and is internalized by fluid-phase endocytosis. Following endocytosis, endosomal 
proteases such as the cathepsins which are upregulated in tumor cells rapidly cleave 
the polymer by virtue of enzymatic recognition of the free lysine residues. Upon 
cleavage, the polymer backbone disintegrates and the Cy5.5 dyes are separated 
spatially. The static quenching is disengaged and the tumors are illuminated with the 
resultant fluorescence. This enzyme-responsive, selective tumor imaging probe was 
also successful in the in vivo imaging of matrix metalloprotease 2 (MMP2) - secreting 
tumor cells by modification of the polymer side chain to include an MMP2 substrate 
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[6]. More significantly, the fluorogenic polymer was used to assess the in vivo MMP 
inhibition of known inhibitors by directly detecting MMP activity in tumors. The 
work by Weissleder and co-workers is considered an important advance in clinical 
molecular imaging and set the stage for developing similar imaging strategies and 
techniques targeting other enzymes. 
  
 In contrast to quenching, fluorescence resonance energy transfer (FRET) is a 
result of long range dipole-dipole interaction between the donor and acceptor, 
resulting in the excess energy from the excited donor fluorophore being transferred to 
an acceptor in the ground state without emission of a photon during the transfer. The 
transfer efficiency is dependent on the distance between the donor and acceptor, the 
extent of overlap of the donor emission spectrum and the acceptor absorption 
spectrum, and the relative orientation between the donor and acceptor. FRET is 
usually efficient up to 100 Å between the donor and acceptor. The acceptor may or 
may not be fluorescent. The use of a fluorescent acceptor results in a construct that 
absorbs at the donor excitation wavelength and emits at the acceptor wavelength when 
the two fluorophores are in close proximity, enabling a ratiometric fluorescence 
response to the distance separating the fluorophores. While enzyme substrates 
utilizing fluorescent donors and acceptors are typically not termed as fluorogenic 
substrates, enzymatic action does result in a fluorescence change in both the donor 
and acceptor emission wavelengths. If a non-fluorescent acceptor is used (“dark 
quencher”), the substrate is optically silent until an enzymatic event causes the 
departure of the quencher from the fluorophore, giving rise to a fluorescence increase. 
This class of substrates have emerged to become the most widely used and versatile in 
design among the different classes of enzymatic substrates used. 
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 The first FRET substrate which was developed by Matayoshi and co-workers 
targeted the human immunodeficiency virus-1 (HIV-1) protease [7]. The FRET 
substrate, (DABCYL)-SQNYPIVQ-(EDANS), contains the 8-amino acid peptide 
sequence that is known to be cleaved by the HIV-1 protease, and a fluorophore 
EDANS which is quenched by the dark quencher DABCYL. Upon cleavage by the 
protease, the fluorophore is separated from the quencher, providing a direct read-out 
of enzymatic activity which could be monitored in a real-time fashion. This seminal 
work establishes a general design of fluorogenic substrates for other proteases, many 
of them are commercially available. 
 
 Recent developments have focused on the use of FRET for the design of non-
peptidic, small molecule-based substrates. One of the first small molecule-based 
FRET substrate was designed for β-lactamases by Tsien and co-workers, with the aim 
of using enzymatically-amplified fluorescence readout for gene expression [8].  
Mammalian cells which were stably transfected with the TEM-1 β-lactamase gene 
regulated by a promoter rapidly gave blue fluorescence from the β-lactamase-
catalyzed hydrolysis of the FRET substrate when the promoter was added which led 
to upregulated gene expression. It was found that the fluorescence intensities 
correlated well with the number of β-lactamases expressed per cell, which could 
enable quantification of the readout. The group also showed that this β-lactamase 
reporter system could also be used for flow cytometry in engineering cell lines with 




 Another important contribution to the use of small molecule-based FRET 
substrates in biological systems can be attributed to the groups of Farber and Pack, 
who synthesized internally quenched phospholipids as substrates for phospholipase 
A2 (PLA2) to assay lipid metabolism in living zebrafish larvae [9]. Ingestion of the 
PLA2 substrate results in cleavage by endogeneous phospholipases and accumulation 
of the fluorescent products in the gall bladder. Mutants that have severely impaired 
phospholipid processing were not fluorescent, thus enabling the researchers to 
generate, efficiently screen and identify genes that are critical in vertebrate digestive 
physiology. 
 
 Further to the two examples highlighted, different groups have improved on or 
developed other small molecule-based FRET substrates for β-lactamases [10], other 
phospholipases [11] and proteases [12] for different applications with one of the 
following aims: enabling near-infrared or ratiometric imaging, or improving the 
selective detection of the target enzyme over others. It is important to note that these 
small molecule-based substrates are extremely useful for assaying small molecule 
metabolism, since there are no genetically encoded substrates that are traditionally 
used for other enzymes, such as proteases. 
 
1.2.2 Fluorophore release after enzymatic cleavage 
 
Many fluorophores, including the coumarins, fluoresceins and rhodamines are 
characterized by an electron-donating aniline or phenol where the lone pair on the 
heteroatom is in conjugation with an extended pi system. Reducing the lone pair 
availability for conjugation through acylation or phosphorylation of phenols at the 
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heteroatom dramatically reduces the fluorescence quantum yield and also leads to 
shifts in the wavelength of maximum absorption. In the case of phenols, alkylation of 
the hydroxyl group also leads to decreased fluorescence because it is the anionic 
phenolate form that is highly fluorescent. Enzymatic deacylation or 
dephosphorylation thus has the reverse effect of “turning on” the fluorescence. This 
unique property governs the design of fluorogenic substrates for hydrolytic enzymes: 
a known enzyme substrate, alternatively termed as the enzyme recognition head, is 
conjugated to the aniline or phenol moiety of the fluorophore which is released only 
upon enzymatic hydrolysis of the substrate-fluorophore bond. Fluorogenic substrates 
adopting this design are perhaps the earliest fluorescent assays developed for 
proteases and phosphatases, their subsequent development and have since branched 
into two major applications: i) high-throughput screening and ii) bioimaging. 
 
Fluorescent assays employing coumarin-based substrates in high-throughput 
screening for profiling proteases came into the spotlight with the work published by 
the groups of Thornberry, Ellman and Craik. Thornberry and co-workers constructed 
a combinatorial positional-scanning library of coumarin-linked fluorogenic peptide 
substrates suited for probing the P2-P4 amino acid preferences of caspases, keeping 
the P1 position constant as aspartic acid [13]. The Ellman and Craik groups 
collectively devised a practical synthesis of a coumarin derivative, 7-amino-4-
carbamoylmethylcoumarin (ACC), and synthetic methods for including 20 
proteinogenic amino acids in the P1 position, as well as the solid-phase synthesis of 
fluorogenic peptide libraries [14]. The ease at which large libraries could be generated 
enabled the same researchers to profile a diverse array of serine proteases. The 
screening platform thus established by these groups has since become a reliable tool 
  9
for probing protease substrate preferences and generating a “fingerprint” for each 
protease under study, thereby allowing the differentiation of closely-related enzyme. 
 The Ellman group then took a step in the direction of assay miniaturization for high-
throughput screening with large libraries. Leveraging on the ease at which these 
libraries can be synthesized, a fluorogenic substrate microarray was fabricated by 
immobilizing the individual hydroxylamine-tagged peptides in a spatially segregated 
fashion onto an aldehyde-functionalized glass slide via oxime formation [15]. In this 
work, the researchers probed the substrate specificity of the serine protease thrombin 
by examining its preferences for individual peptides on a miniaturized fluorogenic 
assay. This had the potential of generating a proteolytic fingerprint of each protease 
rapidly, using minimal amounts of enzymes and substrates, in a single experiment. At 
the same time, our group independently prepared a complementary microarray 
platform for the detection of proteases and other hydrolytic enzymes, such as alkaline 
phosphatases, epoxide hydrolases and acetylcholine esterase, thereby demonstrating 
the generality of the microarray approach for detecting enzyme activity [16]. 
 
Prior to microarray-based studies for phosphatises, traditional assays for 
certain classes of phosphatases (PTPs) typically use phosphorylated coumarins as 
fluorogenic enzyme substrates. In particular 6,8-difluoro-4-methylumbelliferyl 
phosphate (DiFMUP) is now routinely used as a general probe for phosphatase 
activity. The development of specific probes for a target phosphatase using these 
fluorogenic substrates however remain a formidable challenge due to the need for 
incorporation of a bulky fluorophore into the peptide substrate without affecting 
phosphatase binding and activity. Barrios et. al. modified a common phosphatase 
substrate, 4-methylumbelliferyl phosphate, into an amino acid which served as a 
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phosphotyrosine mimic [17]. Incorporation of the unnatural amino acid into a peptide 
substrate of the target tyrosine phosphatase thus furnishes a fluorogenic probe for the 
phosphatase of interest. This simple yet elegant approach holds some promise for 
profiling phosphatase activity using a combinatorial peptide library, analogous to 
protease ‘fingerprinting’ with fluorogenic peptide libraries [18]. 
 
Direct conjugation of the enzyme recognition head to the fluorophore limits 
the type of chemical functionality and consequently the type of enzyme substrates that 
could be constructed. An important contribution to extending the scope of enzymes 
that may be assayed using coumarin-based substrates came from Reymond and co-
workers. The Reymond group added a linker between the enzyme recognition head 
and the fluorophore; upon enzymatic action on the substrate moiety, spontaneous β-
elimination or periodate oxidation of the free alcohol followed by β-elimination 
occurs and the fluorophore is released. This strategy was successfully applied to 
assays for various hydrolytic enzymes, including epoxide hydrolases, transalodolases, 
transketolases and Baeyer-Villigerases. This allowed the researchers to differentiate 
closely-related enzymes via their ‘fingerprints’ using chiral, non-racemic coumarin-
based substrates, a subject that has been extensively reviewed [19]. 
 
Substrates for bioimaging however, seldom utilize coumarin as the 
fluorophore due to its excitation wavelength in the ultraviolet region, which results in 
high background signals from autofluorescence and is damaging to live cells. In place 
of coumarin, the fluoresceins and rhodamines have proven to be suitable fluorophores 
in the bioimaging of caspases and galactosidases. Recently, dual-function probes for 
caspases have been developed to expand the utility of these substrates in clinical 
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bioimaging. This new subgroup of fluorogenic substrates are based on precedent 
fluorogenic probes for caspases, but include an additional tag that may be detected via 
another molecular imaging technique which is more effective for diagnostic clinical 
imaging. Mizukami et al. constructed Gd-DOTA-DEVD-AFC, where the 
fluorescence and 19F magnetic resonance (MR) signals from the fluorine-containing 7-
amino-4-trifluoromethylcoumarin (AFC) fluorophore is suppressed in the intact probe 
[20]. Upon enzymatic cleavage by caspases 3 or 7, the fluorophore is released. The 
gadolinium complex which serves to attenuate the 19F MR signal via paramagnetic 
relaxation enhancement is ineffective when the fluorophore diffuses away, leading to 
both an increase in fluorescence and MR signal in response to enzymatic activity. In a 
similar vein, Xiong and co-workers incorporated a radionuclide in a precedent 
fluorogenic caspase probe for both fluorescence and nuclear imaging in preliminary in 
vivo imaging experiments [21]. 
 
Given that substrates used in high throughput screening and those that are 
suited for bioimaging differ in the type of fluorophore, our group probed the 
possibility of developing fluorogenic probes that are suited for both in vitro assays 
and live cell imaging. We designed and synthesized a new green-emitting fluorophore 
which could be used as a coumarin substitute in microplate- and microarray-based 
assays, and also in live-cell imaging of apoptosis [22]. This work is the subject of 






1.2.3 Fluoromorphic probes 
 
 In contrast to assays for hydrolytic enzymes such as proteases and exo-
glycosidases, assays for other enzymes which catalyze other reaction types which 
cannot be monitored by the use of fluorescently-quenched peptide substrates or 
genetically encoded FP-based protein substrates. These transformations include 
isomerization reactions such peptidyl-prolyl cis/trans isomerases, or redox reactions 
of small molecule metabolites. There are no simple, intuitive guidelines for 
constructing fluorogenic probes for measuring activities of these enzymes.  Suitable 
probes thus require separate design considerations tailored specifically for each 
enzyme. 
 
 Sames and co-workers introduced the concept of ‘fluoromorphic’ molecules as 
part of their ongoing research in designing probes for redox enzymes. The group has 
successfully designed small molecule-based enzyme substrates which are structurally 
modified (“morphed”) by the enzyme of interest to a fluorescent product, hence the 
term ‘fluoromorphic’. In one of the earlier examples of these probes, Sames and co-
workers desigened fluorogenic probes for monoamine oxidases (MAO) A and B 
which utilize a spontaneous indole formation following aerobic oxidation of the 
amine moiety by the MAO enzymes [23]. The indole formation switches on the 
fluorescence of the coumarin core, leading to a fluorescent response to enzymatic 
activity. The same group went on further to design probes for dehydrogenase enzymes 
by making use of the different electronic properties of ketone moiety in the probe and 
the alcohol resulting from dehydrogenase activity [24]. They demonstrated that these 
probes could distinguish the target enzymes in intact cells from numerous other redox 
  13
enzymes which could carry out the same functional group transformation. It should be 
noted that the success of the design and application of these probes depend largely on 
enzyme promiscuity; the construction of probes for highly specific enzymes which do 
not tolerate substrates which loosely resemble the endogeneous substrates still poses a 
formidable challenge.   
 
1.2.4 Fluorescence detection of binding events 
 
 Transferases such as the prenyltransferases and kinases which deliver small 
organic molecules such as lipids, or the inorganic phosphate group respectively to the 
substrate present a different problem in the design of synthetic substrates for reporting 
enzyme activities. While the addition of these chemical groups to the endogeneous 
substrates of these enzymes can have profound effects on protein conformation and 
consequently on protein function, these effects are often not translated to short 
peptides. At the molecular level, however, the addition of charged phosphates or 
highly hydrophobic lipids causes a dramatic change in the local environment 
surrounding the other amino acid residues on the peptide. This has been exploited in 
the design of chemosensors that translates this change into a fluorescent readout, 
effectively relating the level of fluorescence to enzymatic activity. 
 
 One of the earliest examples of the design of such sensors was provided by 
Lawrence and co-workers in 2002, who constructed peptide-based probes for kinases, 
one of the most important enzyme classes extensively involved in cellular function, 
from cell signaling to apoptosis [25]. A peptide sequence known to serve as a 
substrate for protein kinase C (PKC) is appended with a fluorophore with fluorescent 
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properties tunable by metal chelation. Phosphorylation of the peptide by the kinase 
introduces a receptor site for a divalent metal comprising the dicarboxylate moiety on 
the fluorophore and the newly introduced phosphate. Coordination of a divalent metal 
(ATP-associated Mg2+) alters the electronic environment of the fluorophore and 
induces a marked increase in fluorescence. Using a similar strategy, Imperiali and co-
workers incorporated a chelation-sensitive sulfamido-oxine (Sox) unnatural amino 
acid into a kinase probe [26]. This sensor sought to address some shortcomings of the 
probe dveloped by Lawrence by utilizing a less bulky sensor fluororphore which 
displayed a greater increase in fluroescence and spatially segregating the sensing 
moiety and the kinase recognition domain. These probes have recently shown to be 
competent in monitoring protein kinases in complex cellular media [27]. 
  
 In conclusion, this section in this thesis serves to highlight the important 
advances that have been made in enzyme assays as a result of employing organic dyes 
in peptide- or small-molecule based substrates. Continued research is certainly 
necessary in pushing the frontiers of enzyme assays and bioimaging to include 










CHAPTER 2 DEVELOPING NEW FLUOROGENIC SUBSTRATES FOR 
DETECTING PROTEASE ACTIVITY 
 
2.1 Fluorogenic Protease Substrates for Detecting Protease Activity on the 
Microarray and in Live Cells 
 
 Proteases are enzymes that catalyze the breakdown of proteins through the 
hydrolysis of the peptide bond. Approximately 2% of the human genome codes for 
proteases, which translates to at least 500-600 proteases identified to date [28]. 
Proteases are classified according to the mechanism of hydrolysis. There are four 
major classes of human proteases: the cysteine, serine/threonine, aspartic proteases 
and the metalloproteases. The first two classes hydrolyses the substrate by using an 
active site residue (Cys, Ser/Thr respectively) for nucleophilic attack on the amide 
bond, while the aspartic and metalloproteases use an activated water molecule as a 
nucleophile. Protease function was initially thought to be limited to the degradation of 
proteins associated with the food digestion process or for the intracellular recycling of 
amino acids. However, studies have revealed the roles of proteases in more complex 
biological processes such as signaling cascades. Excessive or inappropriate 
proteolysis leads to unwanted activation of protease signaling pathways, which may 
lead to detrimental physiological and pathological conditions. Consequently, many 
proteases have emerged as potential drug targets in disease states where the 
modulation of protease activity can have a corrective effect on aberrant or insufficient 
protease activity [29]. Understanding the protease in its native environment and its 
role in protease cascades is of paramount importance in validating the protease as a 
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drug target. This involves the identification of the protease’s endogenous substrates 
and the downstream effects of cleavage of these substrates. 
 
 To aid in the identification of endogenous protease substrates, researchers 
have developed several approaches to profile the substrate specificity of the proteases. 
The mapping of residue preferences at each binding pocket of the protease can enable 
the prediction of substrate sequences that are cleaved in vivo, which in turn help to 
identify the endogenous protein substrates. These typically involve the construction of 
peptide libraries, either synthesized chemically or displayed biologically, and 
assessing the residues (Pn – Pn’) that are most preferred at each position (Sn – Sn’) [30]. 
The standard nomenclature used to designate substrate/inhibitor residues that bind to 
corresponding enzyme subsites is shown in Figure 2.1a. The optimal peptide sequence 
derived from such studies may be converted to a fluorogenic peptide substrate to 
detect protease activity in inhibitor screening and in live cells. These fluorogenic 
substrates emit a fluorescence signal after it is cleaved by the protease of interest. 
Recording the fluorescence readout over a period of time gives the kinetics of the 
enzymatic reaction. This fluorescence signal is also often the mode of detection for 
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Figure 2.1. a) Protease and protease substrate nomenclature. b) 2 types of synthetic peptide 




Fluorogenic peptide substrates, including those employing latent fluorophores, 
internally quenched and fluorescence resonance energy transfer (FRET)-based 
substrates, have emerged as indispensable tools in the profiling and visualization of 
protease activities both in vitro and in vivo [31]. Two types of synthetic fluorogenic 
peptides are widely used in high-throughput screening of protease inhibitors: i) 
extended FRET-based peptide substrates containing fluorophore and a dark quencher 
and ii) fluorogenic peptide substrates containing a C-terminally capped coumarin 
derivative (i.e. 7-amino-4-methylcoumarin (AMC) or 7-amino-4-
carbamoylmethylcoumarin (ACC)). The fluorescence in FRET-based substrates is 
suppressed by the dark quencher which absorbs the light emitted by the fluorophore. 
Cleavage of the peptide substrate results in the spatial separation of the fluorophore 
and quencher. Energy transfer becomes extremely inefficient and negligible, leading 
to an increase in fluorescence from the fluorophore. AMC-/ACC-based substrates 
contain a coumarin moiety which is fluorescently silent when capped with a peptide 
sequence. They are arguably the most useful for substrate specificity profiling 
experiments, as only cleavage at the amide bond between the peptide and the 
coumarin moiety will release the highly fluorescent coumarin [32]. Consequently, 
coumarin-based fluorogenic peptide libraries have been employed to study the 
substrate specificities of numerous therapeutically important proteases, including 
caspases, thrombin, cathepsins and many others. In recent years, several attempts 
have been made to introduce these substrate libraries to microarray-based applications 
where further miniaturization and higher throughput of enzymatic assays can be 
achieved [15, 16]. We and others recently reported the immobilization of coumarin-
based enzyme substrates onto microarray platforms and used them to profile substrate 
specificities of proteases. Since coumarin dyes are excited in the UV region 
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(maximum λex ~350 nm), these strategies have not been effective due to high 
fluorescence backgrounds and the lack of microarray scanners with UV light sources. 
For similar reasons, coumarin-based peptide substrates are rarely used in live-cell 
imaging experiments.  The aim in this current work is thus to replace coumarin with a 
new fluorophore having excitation and emission wavelengths in the visible range, so 
that it can have dual utilities in both microarray and live-cell imaging applications.  
 
 
2.2 Design of a New Fluorophore for Microarray and Bioimaging Applications 
 
In designing a suitable fluorophore, we turned to other fluorescein and 
rhodamine fluorophores that have been used for labeling reagents and enzymatic 
assays [34]. Of these, Rhodamine 110 (R110)-based substrates are well-established 
peptide probes for serine and cysteine proteases [35, 36]. Despite the desirable 
fluorescence properties of R110, several drawbacks hinder the direct use of these 
substrates: (1) R110-conjugated peptides require both peptide groups to be cleaved in 
order to generate maximum fluorescence, and thus are not suitable for quantitative 
studies of linear enzyme kinetics; (2) ‘asymmetric’ versions of these dyes containing a 
single peptide cleavage site lack an immobilization handle which is essential for both 
solid-phase peptide synthesis and microarray applications; (3) equilibrium between 











Figure 2.2. Structures of common fluorophores used in fluorogenic peptide substrates (ACC 
and Rhodamine 110) and fluorophores from which Singapore Green was derived (Rhodamine 
110 and Tokyo Green). 
 
Our new fluorophore, Singapore Green (SG), is a hybrid of R110 and the 
fluorescein analog 2-Me TokyoGreen [37], with a phenolic group on one end 
providing a chemical handle (for solid-phase peptide synthesis, microarray 
immobilization and potentially other applications in cell-based experiments), and an 
amino group on the other end serving as the point of conjugation to a peptide 
sequence (Figure 2.2). We reasoned that, amidation at the amino group of SG by a 
peptide should suppress the fluorescence of the dye, similar to coumarin-based 
peptide substrates. Cleavage of the amide bond by a protease should release the highly 
fluorescent SG, thus reporting protease activity accordingly. Herein, we report the 
synthesis and characterizations of SG, the solid-phase synthesis of SG-conjugated 
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2.3 Chemical Synthesis of SG and SG-Conjugated Peptides 
 
































Scheme 2.1. Initial proposed synthesis of SG-COOH. 
 
 In designing a synthesis strategy to SG and its related derivatives, we first 
conceived a route that took advantage of a published xanthone intermediate [38] 
which was subsequently protected with a trityl group on the aniline (Scheme 2.1). 
Grignard addition of o-tolylmagnesium bromide to the ketone gave the corresponding 
xanthene which could undergo alkylation to install a linker functionalized with a 
protected carboxylic acid at the end for anchoring onto the resin for solid-phase 
synthesis. However, during the course of the synthesis, it was found that the TBS 
group was cleaved off during the Grignard reaction before acidic work-up. This was 
an unusual occurrence since this protecting group is well-known for its stability under 
strongly basic anhydrous conditions. We reasoned that deprotection of the silyl group 
resulted from the nucleophilic attack of the Grignard reagent with the phenoxide 
anion acting as a stable leaving group. The extra stability of the phenol is conferred by 
the delocalization of the negative charge into the neighbouring carbonyl group. This 
enol form is stabilized by the extended conjugated system of the planar xanthone unit 
(Figure 2.3). Due to this delocalization, the C=O carbon is less electrophilic and the 
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reactivity towards nucleophiles is greatly reduced. This led to a sluggish Grignard 
reaction in which the starting material remained unconsumed even after 3 days of 












less electrophilic than 
usual C=O carbon
 
Figure 2.3. Resonance stabilization of phenolate anion resulting from TBS deprotection 
 
The subsequent alkylation also proceeded slowly as the stable xanthene core existed 
predominantly as the ketone form and O-alkylation required a shift in electron density 
to the oxygen atom in the imine form. The imine form is thermodynamically less 
stable and is disfavored due to increased steric clash between the xanthene rings and 
the three bulky phenyl rings of the trityl group resulting from the rigid C=N bond 
(Figure 2.4). Both elevated temperatures (60οC) and microwave heating (70οC) for 30 













Figure 2.4. The 2 major resonance structures of the asymmetric xanthene. The ketone form 
suffers less from steric clash between the 3 phenyl groups and the xanthene core due to a 
rotatable C-N bond, while the imine form has a rigid C=N bond and is thermodynamically less 
stable. Subsequent alkylation with an alkyl bromide is inefficient due to slow equilibration to 
the imine form. 
 
 In face of these 2 synthetic problems involving advanced intermediates, we 
conceived another strategy in which the linker unit was installed early in the route. 
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We reasoned that the ether linkage on the phenol should be stable during the Grignard 
reaction and the carbonyl carbon will thus be more reactive in the nucleophilic 
addition. This synthesis route was tried and optimized as shown in Scheme 2.2. We 
decided to synthesize both SG1, a simple methyl ether as a green-fluorescing analog 
of AMC for spectroscopic analysis and SG2 with the same fluorophore structure with 




























1. K2CO3, Cu, DMF, 130oC
2. H2SO4, 80oC







2-3a: R = CH3 (70%)
2-3b: R = (CH2)5OTBS (82%)
2-4a: R = CH3 (90%)
2-4b: R = (CH2)5OTBS (92%)
2-5a: R = CH3 (88%)
2-5b: R = (CH2)5OTBS (97%)
MgBr
SG1 (68%)
1.                   , THF, 50οC
2. DCM/TFA/H2O 7:2:1





Scheme 2.2. Synthesis of SG1 and SG2. 
 
The synthesis of SG started with the formation of the asymmetric xanthone 1, 
which was generated by Ullman-type coupling between 3-acetamidophenol and 2-
chloro-4-nitrobenzoic acid based on a published procedure. Diazotization of the 
amino group and hydrolysis of the diazonium salt yielded the phenol 2 which 
underwent methylation or alkylation with a linker unit to give 3. The nitro group was 
subsequently reduced to give 4a and 4b. Subsequent trityl-protection and Grignard 
addition of o-tolyl magnesium bromide followed by deprotection of the trityl group 
afforded the fluorophores SG1 and SG2, respectively. 
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2.3.2 Derivatization of SG1 and SG2 and Solid-Phase Synthesis of SG-
Conjugated Peptides as Fluorogenic Protease Substrates 
 
To test if peptide conjugates of SG1 can be used as fluorogenic probes to 
detect enzymatic activity, we synthesized Ac-DEVD-SG1 as an analog of Ac-DEVD- 
AMC, a coumarin-based substrate for the enzymes caspase-3 and caspase-7 from 
commercial sources. We adopted a solid-phase approach for the synthesis of the 
tetrapeptide. To this end, SG1 was first coupled in solution to Fmoc-Asp(OtBu)-OH 
using standard peptide coupling reagents, HBTU, HOBt and DIEA, followed by TFA 
deprotection of the t-butyl ester on the Fmoc-Asp moiety, leaving a free acid, Fmoc-
Asp-SG1 for loading onto solid support for the subsequent peptide synthesis (Scheme 
2.3). 2 types of resins were suitable for our purposes: the Wang (p-benzyloxybenzyl 
alcohol) and the 2-chlorotritylchloride resins. Loading of an acid onto Wang resin 
typically involves pre-activation of the acid by carbodiimide reagents, e.g. 
diisopropylcarbodimide (DIC) to form a symmetrical anhydride followed by addition 
of the anhydride dissolved in DCM and a catalytic amount of DMAP to the alcohol-
functionalized resin to form an ester linkage. This procedure was first tried but 
loading onto Wang resin could not be carried out due to unsuccessful formation of the 
symmetrical anhydride of Fmoc-Asp-SG1. Instead, the N-acylurea formed between 
DIC and Fmoc-Asp-SG1 was found. This side reaction took place possibly because of 
the low nucleophilicity of the carboxylate anion which is hindered from attack by the 



























Figure 2.5. Formation of the undesired N-acylurea from Fmoc-Asp-SG1 and DIC. The 
carboxylic acid is first deprotonated by DIC to form the carboxylate anion as the active 
nucleophile which adds to DIC. In the absence of a second nucleophile, an intramolecular 
NO acyl shift takes place to form the N-acylurea from the O-acylisourea. 
 
Following this observation, we tried loading Fmoc-Asp-SG1 onto the 2-
chlorotritylchloride resin with the use of a weak base, N,N-diisopropylethylamine 
(DIEA). The reaction was rapid and loading was successful with just 2 h of reaction 
time. While converting Fmoc-Asp-SG1 to an acid chloride and coupling onto Wang 
resin was another viable option, we chose the 2-chlorotritylchloride resin for 
subsequent peptide synthesis as it did not require further manipulation of Fmoc-Asp-
SG1 (Scheme 2.3). Standard peptide synthesis on solid phase was carried out using 
the well-established Fmoc chemistry. Deprotection of the side chain protecting groups 
and cleavage from solid support with TFA and TIS as a radical scavenger afforded 
Ac-DEVD-SG1. To characterize the tetrapeptide product, LC-MS analysis was 
carried out. The desired product was obtained in good purity. (Figure 2.6) 
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Scheme 2.3. Derivatization of SG1 and solid phase synthesis of caspase-3/7 probe, Ac-
DEVD-SG1. Reagents and conditions: (a) Fmoc-Asp(OtBu)-OH, HBTU, HOBT, DIEA, 2 h; (b) 
20% TFA/DCM, 5 h; (c) DIEA, DCM, 2h; (d) i: 20% piperidine/DMF, 30 min; ii: Fmoc-Val-OH, 
HBTU, HOBt, DIEA, DMF, 3 h; (e) i: 20% piperidine/DMF, 30 min; Fmoc-Glu(OtBu)-OH, 
HBTU, HOBt, DIEA, DMF, 3 h; (f) i: 20% piperidine/DMF, 30 min; ii: Ac-Asp(OtBu)-OH, HBTU, 
HOBt, DIEA, DMF; (e) TFA/TIS (95:5), 2.5 h. 
 






































We next sought to test the feasibility of using peptide conjugates of SG2 for 
reporting protease activities on the microarray. We picked 10 peptide sequences from 
commercially available p-nitroanilide or coumarin-based substrates targeting various 
proteases and replaced the p-nitroaniline chromophore or coumarin fluorophores with 
SG2. While the synthesis of Ac-DEVD-SG1 was straightforward, the same strategy 
could not be applied to all peptide sequences as it required a functional group on the 
first amino acid that could be attached to the resin, which precludes amino acids with 
alkyl side chains. We thus used another approach for the synthesis of these 10 
different peptide sequences containing SG2. The alcohol functional group could be 
oxidized to an aldehyde which could serve as both an anchor to the resin and for 
attachment to functionalized glass slides for microarray-based experiments. To render 
the fluorophore compatible with Fmoc-based chemistry used in solid-phase peptide 
synthesis, the amino end of SG2 was protected with Fmoc, giving 2-8 and the 
hydroxyl-containing linker at the other end was oxidized to an aldehyde with Dess-












Scheme 2.4. Synthesis of Fmoc-SG2-CHO (2-9) for peptide synthesis 
 
 We adopted a solid-phase synthetic strategy that had been used for the 
preparation of peptide aldehyde libraries on threonine-functionalized resin [39]. As 
shown in Scheme 5, this functional resin was synthesized from aminomethyl 
polystyrene resin using standard Fmoc chemistry for peptide couplings. This was 
followed by deprotection of the Fmoc group with 20% piperidine in DMF and the 
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tert-butyl ether group with 95% TFA/TIS. The resulting ammonium salt was 
neutralized by stirring the resin in 10% DIEA/DCM to give a 1,2-amino alcohol. 
Fmoc-SG2-CHO was then loaded onto the resin via acid-catalyzed oxazolidine 
formation. Following Boc protection of the secondary amine to prevent acylation and 
hydrolytic cleavage of the oxazolidine ring during peptide synthesis, Fmoc 
deprotection of the resin-bound SG2 was carried out and standard solid phase peptide 
synthesis ensued. The N-terminus of the peptide was capped with an acetyl group 
using acetic anhydride, followed by deprotection of the amino acid side chains and the 
Boc group on the oxazolidine with dry TFA. For peptides containing Arg, 1% H2O 
was included as a scavenger for the released Pbf group and the deprotection was 
prolonged to 2 h to ensure complete deprotection. The SG2-peptide conjugates were 
then released from the solid support by acid-catalyzed hydrolysis of the oxazolidine 

























































































Scheme 2.5. Solid phase synthesis of aldehyde-functionalized SG2-peptide conjugates. 
Reagents and conditions: (a) i: Fmoc-Gly-OH, HBTU, HOBt, DIEA, DMF, 2 h; ii: 20% 
piperidine/DMF, 30 min. (b) Fmoc-Thr(OtBu)-OH, HBTU, HOBt, DIEA, DMF, 2 h. (c) i: 20% 
piperidine/DMF, 30 min; ii: TFA/TIS (95:5) 1 h; iii: 10% DIEA/DCM. (d) Fmoc-SG2-CHO, 
MeOH/DCM/DMF/AcOH 6:2:1:1. (e) Boc2O, DIEA, DCM, 3 h. (f) 20% piperidine/DMF, 30 min. 
(g) TFA/TIS (95:5) or TFA/TIS/H2O (95:4:1), 45 min – 2 h. (h) DCM/MeOH/AcOH/H2O 
(12:5:2:1) 
 
used without purification for subsequent enzymatic screening. The crude products 
with the exception of P9 showed a single major peak in LC-MS profiles, thus 
demonstrating the compatibility of SG2 with standard Fmoc chemistry (Figure 2.7). 
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Ac-FG-SG2-CHO. IT-TOF-MS: m/z [M+1]+ calcd: 632.268, found 632.212. 



















Ac-EY-SG2-CHO. IT-TOF-MS: m/z [M+1]+ calcd: 720.284, found 720.227. 






















Ac-FRR-SG2-CHO. IT-TOF-MS: m/z [M/2+1]+ calcd: 444.225, found 444.180. 























Ac-AAF-SG2-CHO. IT-TOF-MS: m/z [M+1]+ calcd: 717.321, found 717.246. 

























Ac-AAL-SG2-CHO. IT-TOF-MS: m/z [M+1]+ calcd: 683.337, found 683.306. 























Ac-VPR-SG2-CHO. IT-TOF-MS: m/z [M+1]+ calcd: 780.401, found 780.315. 























Ac-DEVD-SG2-CHO. IT-TOF-MS: m/z [M+1]+ calcd: 886.343, found 886.242. 




















Ac-YVAD-SG2-CHO. IT-TOF-MS: m/z [M+1]+ calcd: 876.374, found 876.265. 



















Ac-ENLYFQ-SG2-CHO. IT-TOF-MS: m/z [M/2+1]+ calcd: 611.769, found 611.711. 


















Ac-RPFLLHVY-SG2-CHO. IT-TOF-MS: m/z [M/2+1]+ calcd: 727.380, found 
727.271. 




















Figure 2.7. LC-MS profiles of the 10 SG2-peptide conjugates. LC conditions: 10-100% 
CH3CN in 20 min. 
 
 
2.4 Profiling Protease Activity in Microplate and on the Microarray 
 
We first evaluated the spectroscopic properties of SG1 to determine its 
suitability for integration into a fluorescence reporter system. SG1 was found to have 
excitation maxima at 469 and 473 nm and emission maxima at 517 nm in ethanol (Fig 
2.8), similar to fluorescein (494 and 521 nm respectively, in water), and is thus 
compatible with the 488 nm argon-ion laser used in most microarray scanners and 
fluorescence microscopes. SG1 has a quantum yield of 0.50 and an extinction 
coefficient of 28500 M-1cm-1 which is reasonably bright for most applications. With 
the 11 SG-peptide conjugates in hand, our aim was to evaluate them as synthetic 
substrates for assaying protease activity on both the conventional microplate platform 
and the microarray.  
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Figure 2.8. a) Protease cleavage of SG-peptide conjugates. Enzymatic hydrolysis of the 
anilide bond results in a fluorescence increase due to the release of SG. b) Excitation (blue) 
and emission (red) spectra  of SG1. c) Fluorescence increase from cleavage of Ac-DEVD-
SG1 by caspase-3 (blue) and caspase-7 (red) over the background fluorescence (orange) 
 
We next tested Ac-DEVD-SG1 which contains the optimal substrate sequence 
for the cysteine proteases caspase-3 and -7. Ac-DEVD-SG1 was weakly fluorescent. 
Upon incubation with caspase-3 and -7, there was a time-dependent increase in 
fluorescence resulting from the cleavage of the amide bond between the Asp residue 
and SG1. The fluorescence increase follows typical Michaelis-Menten kinetics, 
indicating that SG-based peptide conjugates are indeed suitable green light-emitting 
substitutes of the well-established coumarin-based substrates.  
 
 Having shown the feasibility of using our tetrapeptide SG-conjugated 
substrate to report proteolysis, we moved to the microarray platform, where the 
































surface. Proteolysis results in a fluorescence signal on the glass slide, which is 






















































Figure 2.9. Detecting protease activity on the microarray. 
 
To generate our peptide microarray, glass slides had to be appropriately 
functionalized with hydroxylamines for chemoselective ligation with the SG2-peptide 
aldehydes. This was accomplished by washing the glass slides in piranha solution 
(conc. H2SO4/ 30% H2O2 7:3) which hydroxylates the glass surface, forming silanols. 
The exposed silanols are then reacted with aminopropyltriethoxysilane in the presence 
of a small amount of water to yield disiloxanes with an amine terminal. The amine-
functionalized slides were then coupled with a phthalimide-protected hydroxylamine 
linker using standard coupling reagents for amide bond formation. The phthalimide 



















































Scheme 2.6. Functionalization of glass slides with alkoxyamines. The actual Si species on the 
glass surface is probably a mixture of cross-linked disiloxanes and free silanols. 
  
We selected peptide sequences that were known substrates for proteases of 
different classes, and also of different specificity to test the robustness of our platform 
in screening for protease activity (Table 2.1).  
 
Peptide no. Peptide sequence Target Protease Protease Class 
P1 Ac-FG-SG2-CHO Papain Cysteine 
P2 Ac-EY-SG2-CHO Pepsin Aspartic 
P3 Ac-FRR-SG2-CHO Trypsin Serine 
P4 Ac-AAF-SG2-CHO Chymotrypsin Serine 
P5 Ac-AAL-SG2-CHO Subtilisin Serine 
P6 Ac-VPR-SG2-CHO Thrombin Serine 
P7 Ac-DEVD-SG2-CHO Caspase-3/-7 Cysteine 
P8 Ac-YVAD-SG2-CHO Caspase-1 Cysteine 
P9 Ac-ENLYFQ-SG2-CHO TEV Cysteine 
P10 Ac-RPFHLLVY-SG2-CHO Rennin Aspartic 
 
Table 2.1. Peptide sequences synthesized and their target proteases. 
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Cysteine proteases such as the caspases and TEV have stringent substrate 
specificity, requiring a specific peptide sequence for binding and catalysis to occur, 
while other proteases such as subtilisin has broader specificity. The fourth class of 
proteases, the metalloproteases, were not included as they generally require substrate 
recognition on the prime sites and thus their activity could not be monitored by our 
designed substrates.  
 
We spotted the aldehyde-functionalized peptides onto the hydroxylamine 
slides to generate the corresponding peptide microarray via oxime bond formation. As 
a proof-of-concept experiment, the immobilized peptides were treated with four 
different proteases (caspase-3, caspase-7, α-chymotrypsin and subtilisin). The 
microarray was subsequently scanned with a microarray scanner equipped with a blue 
light source. Images obtained immediately revealed discerning “substrate 
fingerprints” of each enzyme. Of the proteases used, enzymes with broader substrate 
specificity (subtilisin and α-chymotrypsin) cleaved multiple substrates to different 
extents, while highly specific proteases (caspase-3 and -7) cleaved only its optimal 
substrate sequence, Ac-DEVD-SG2.  
 





Figure 2.10. a) Enzyme “fingerprints” obtained (clockwise from top left: a-chymotrypsin, 





P2 P4 P6 P8 P10 


















dependent kinetic profiles obtained from the peptide microarray. Peptides were spotted in 
duplicate vertically. 
 
We next examined whether the SG-based peptide microarray could be used to obtain 
quantitative enzyme kinetic data by incubating four selected peptides with four 
different enzymes in a time-dependent experiment. Fluorescence intensities were 
quantified and fitted to kinetic curves to obtain kobs values which reflected the 
substrate preferences of the proteases. Taken together, these experiments indicate the 








































































































R2 = 0.98 
kobs = 0.18 
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Figure 2.11. a) Selected kinetic data from microarray enzymatic assays shown in Figure 2.10. 
b) Microplate assays for the corresponding enzyme/peptide pair carried out as a comparison. 
 
 
2.5 Imaging Caspase-3 and-7 Activities in Live Cells 
 
To demonstrate that our SG-based substrates can be used for live-cell imaging, 
we tested the ability of Ac-DEVD-SG1 to image apoptosis in live cells. Caspase-3 
and -7 are key mediators of this important biological process where improper 
regulation of caspase activity has detrimental pathological and physiological effects. 
To image apoptosis, numerous peptide- and protein-based probes including 
Rhodamine 110 peptide conjugates have been developed from the sensitive detection 
of caspase activity [40,41]. We thus evaluated Ac-DEVD-SG1 as a fluorogenic probe 
for reporting caspase-3 and -7 activity in apoptotic HeLa cells. Cells treated with Ac-
DEVD-SG1 developed a strong green fluorescence upon apoptosis induction with 
staurosporine. In contrast, no significant increase in green fluorescence was observed 
in non-apoptotic cells even after extended incubation time. Non-apoptotic cells 
remained viable after treatment with the probe for more than 3 h, indicated that the 
probe was not cytotoxic. 
 
 
R2 = 0.99 
kobs = 0.097 
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Figure 2.12. Detecting caspase activity in live HeLa cells with Ac-DEVD-SG1. Cells were 
injected with 50 µM of Ac-DEVD-SG1 with tetramethylrhodamine-dextran as marker to 
identify injected cells in RFP channel. a) Injected cells before apoptosis induction. b) Cells 
showed a fluorescence increase in the GFP channel after treatment with staurosporine. Scale 





In conclusion, we have designed and synthesized a new green light-emitting 
fluorophore, Singapore Green (SG), which possesses desirable chemical and 































fluorescence properties suitable for biomedical applications. We have shown that 
peptide conjugates of this new fluorophore can be readily synthesized using standard 
solid-phase peptide chemistry, and conveniently immobilized on a microarray for 
high-throughput substrate specificitiy profiling of proteases. We further showed that 
these probes are equally amenable for live-cell imaging of protease activities. To date, 
positional scanning libraries of coumarin-based peptide substrates are most commonly 
employed in profiling studies of proteases. These probes are however largely 
unsuitable for bioimaging purposes as the coumarin fluorophore has an excitation 
wavelength in the UV region and emission in the blue region where there is 
significant background fluorescence. As a result, optimal substrates derived from 
profiling studies cannot be directly be used as imaging agents for protease activity. By 
introducing SG, a fluorescein analog of ACC or AMC, this dual purpose may now be 
achieved. We anticipate that this chemically amenable fluorophore and its quenched 
peptide substrates will become useful tools for further developments in enzyme 












CHAPTER 3 FLUOROGENIC PROBES FOR DETECTING PROTEASE 
ACTIVITY AT SUBCELLULAR LOCATIONS 
 
3.1 Targeted Delivery of Molecules into the Cell 
 
 The central theme in drug delivery research is the delivery of biologically 
active molecules to their primary site of action to increase therapeutic efficacy. This 
multi-faceted problem of involves several major issues: i) cell-specific targeting to 
ensure that therapeutics act on malignant cell types only; ii) transporting molecules 
into the intracellular space; and iii) delivering them to specific organelles where their 
intended targets are located. In recent years, researchers have been interested in 
adapting the methods developed for intracellular delivery to other biologically 
interesting molecules, as well as understanding the precise mechanisms of cellular 
uptake and internalization. Notably, a growing trend that has emerged is the shift of 
focus from enhancing cell permeability to attaining organelle-specific targeting. This 
stems from the general observation that cellular entry does not equate to access to the 
intended site of action within the cell for the molecule of interest, thereby largely 
diminishing the efficacy of various molecular transporters as true delivery vehicles. 
Academic researchers have henceforth embarked on the task of understanding the 
transport mechanisms associated with each organelle from a molecular perspective 
through the use of probes that interrogate organelle function or individual protein 
function within the organelle of interest. 
 
 One of the major breakthroughs in cellular delivery came about through the 
discovery of peptide sequences which can efficiently translocate across the cell 
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membrane, known as cell-penetrating peptides (CPPs). The two most well-known 
CPPs are the Tat peptide [42] and Penetratin [43], derived respectively from the 
human immunodeficiency virus (HIV) transcriptional regulator Tat and the 
Drosophila transcription factor Antennapedia. These short peptide sequences of less 
than 20 amino acids were found to act as efficient carriers of diverse cargoes such as 
proteins, peptides and oligonucleotides conjugated to the peptides [44]. Synthetic 
analogues of these peptides, such as the oligoarginines, comprise the other family of 
CPPs. Since CPPs are easily synthesized by chemical methods, and may be 
genetically fused with protein cargoes, they are now routine tools for the general 
intracellular delivery of biologically active molecules. One of the major problems 
associated with the use of CPPs, however, has been the vesicular entrapment of the 
cargoes being trafficked. Endocytosis competes significantly with direct cell 
penetration in which the cargo is directly delivered into the cytoplasm. Cargo which 
has been internalized by endocytosis and fails to escape from the endosomes is 
eventually destroyed in the lysosomes, the cell’s demolition center, which means that 
the actual amount of cargo that is able to act on its target is less than that administered. 
Because the precise molecular mechanisms of the competing processes of endocytosis 
and penetration have not been elucidated, it remains difficult to manipulate them such 
that the latter process predominates. The true utility of CPPs as delivery vehicles is 
thus diminished. 
 
 The abovementioned limitation of using CPPs highlights the question 
underpinning drug delivery research – how efficiently is the molecule of interest 
delivered to its intended site of action? One of the recent directions undertaken to 
address this issue is the design of methods to deliver the molecules of interest directly 
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to the organelle where they can perform their function. This concept of subcellular 
targeting is perhaps most well-demonstrated in therapeutic strategies used to modulate 
mitochondrial function. One of these strategies is the use of proapoptotic peptides, 
which once delivered into the tumor cell, permeabilize the mitochondrial membrane, 
resulting in the release of cytochrome c and leading to apoptotic death of the tumor 
cell. The selectivity of these peptides towards the mitochondrial membrane over the 
plasma membrane is critical for therapeutic use of these peptides. Peptides that cause 
cell lysis by permeabilization of the plasma membrane will not be effective since they 
cannot be made to recognize tumor cells by the attachment of tumor cell-specific 
moieties. Several reports describe the successful applications of such mitochondria-
targeting, tumor-specific peptides [45]. In addition to its role in apoptosis, the 
mitochondrion is also the site where reactive oxygen species reside. Oxidative stress 
caused by reactive oxygen species has been linked to various diseases [46, 47], and 
this is found to be reduced through the use of radical scavengers such as TEMPO [48]. 
To address the problem of poor cell-permeability of these nitroxide scavengers, Wipf 
and co-workers designed and synthesized TEMPO derivatives conjugated to a 
membrane-active peptide sequence from the natural antibiotic Gramicidin S [49]. The 
resulting constructs were cell-permeable, mitochondria-targeting radical scavengers 
which prevented the increase in intracellular superoxide production induced.  
 
 An important lesson can be learnt from these studies and numerous other 
strategies [50] developed to home in on the mitochondria. Researchers have 
recognized the importance of organelle targeting to achieve the desired therapeutic 
effect, but this has surprisingly not been utilized in small molecule drug discovery. A 
recent study by the Simons group [51] may mark a paradigm shift in inhibitor 
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development. They studied the inhibition of β-secretase, an endosomal protease 
whose aberrant activity is known to propagate Alzheimer’s disease with a known 
inhibitor and the same inhibitor attached to a sterol moiety which was a membrane 
anchor. The group showed that the sterol-linked inhibitor was effectively internalized 
by endocytosis after membrane anchoring, allowing it to inhibit the β-secretase within 
the endosome. This targeted inhibitor was shown to be markedly more potent than the 
free inhibitor, giving a definitive example of how understanding protein 
compartmentalization can lead to the design of inhibitors with better in vivo profiles 
by the single attachment of a targeting moiety. This principle could pave the way for 
the design of next-generation inhibitors and therapeutics which can home in on the 
specific organelle where their target resides, while escaping non-productive 
internalization pathways. It also calls for the re-evaluation of known inhibitors in the 
cellular context, from the perspective of addressing the localization of these inhibitors 
within the cell. 
 
 Given the prospects of organelle-specific inhibitors or molecules that mediate 
protein function, enabling strategies which allow the identification and detection of 
resident proteins in these organelles should become important. In recent years, there 
have been a number of noteworthy reports on the global analysis of protein 
subcellular localization by imaging FP-tagged proteins [52]. These systems biology 
approaches serve to assign individual proteins to their respective organelles or to 
characterize the proteins within an organelle, but do not report the functional state of 
these proteins. Activity-based protein labeling and detecting enzyme activity in 
subcellular locations will thus provide another dimension to studying both the protein 
of interest in its subcellular microenvironment and organelle function as a whole. 
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There are some recent developments in this aspect. Overkleeft and co-workers 
developed an activity-based probe targeting cathepsins in antigen-presenting cells by 
modifying a known cathepsin probe with a mannose cluster to facilitate uptake 
through receptor-mediated endocytosis [53]. This process brings the probe to its target 
proteases in the lysosomes, enabling the fluorescent tagging of the proteases. 
Activity-based probes are well-poised for studies in organellar studies as they have 
proven to be powerful tools for protein profiling both in vitro and in vivo for different 
applications [54]. Overkleeft’s targeted probes present a plausible general strategy for 
developing future probes useful for interrogating the subcellular proteome. 
 
 The most direct assessment of enzyme activity is the use of enzyme substrates 
which gives an easily measurable readout after the enzymatic reaction. They have 
long been used to assay enzyme activity for inhibitor development, but there have 
been recent developments in adapting known fluorogenic substrates for imaging. In 
particular, synthetic peptide substrates have been used routinely for imaging proteases 
and are thus used in efforts to develop improved substrates. Many of these efforts aim 
to develop improved substrates by increasing the cell permeability of the substrate for 
efficient cellular uptake and/or modifying substrates for practical use in in vivo 
systems [55]. There are however, few examples that report substrates which can 
image enzymatic activity that is confined within an organelle [56]. There is thus a 
need to develop fluorogenic substrates which can image the target enzymes in various 
subcellular locations. Imaging agents, activity-based probes and inhibitors targeted to 
specific organelles will constitute a multi-pronged approach to advance studies of the 
proteome at the subcellular level. 
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3.2 Design of Cell-Permeable Protease Substrates Targeting Different Organelles 
 
We recently developed a series of fluorogenic peptide substrates that could be 
used for detecting protease activity on the microarray and in live cells. We designed 
our fluorophore, SG2, a green light-emitting substitute for the blue-fluorescing ACC 
fluroophore, to be a versatile fluorophore which can be attached to other 
functionalities for various applications [22]. The long alkyl linker functionally 
separates SG2 from other appendages at the other end of the linker and enables 
synthetic manipulation without the need to re-synthesize the xanthene core structure. 
In the previous chapter, we synthesized SG2-peptide conjugates by using the linker 
with an aldehyde moiety as a point of attachment to the solid support and to the 
microarray glass slides. We also used the SG1-based peptide substrate, Ac-DEVD-
SG1, in imaging caspase -3/7 activity in apoptotic live cells. We also established that 
these dye-peptide conjugates can easily be synthesized using well-established Fmoc 
chemistry for solid-phase peptide synthesis. In addition, having demonstrated the 
compatibility of our SG-peptide conjugates in live-cell imaging, we looked to 
delivering substrates targeting various enzymes into different organelles within the 
cell to image protease activity in intracellular locations.  
 
One of the modes of delivering a cargo into a cell is the use of peptide 
sequences that are known to localize a protein to a particular organelle. Because 
enzymes can be localized at multiple organelles, or translocated from one organelle to 
another, we needed a synthetic strategy that would allow us to easily attach different 
localization sequences to different substrates.  
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We thus conceived a strategy in which the fluorogenic peptide substrates and 
the localization sequences are synthesized as separate modules and assembled using a 
ligation reaction. This reaction should be efficient and orthogonal to all the functional 
groups on the peptides since no protecting groups will be present after peptide 
synthesis, and should preferably be carried out under mild, water-compatible 
conditions. The best candidate reaction with the desired characteristics is the Cu(I)- 
catalyzed azide-alkyne cycloaddition, the best known reaction in “click” chemistry 
[57]. To this end, we attached an alkyne handle to each of the peptide substrates and 
an azide moiety to each of the localization sequences. The desired fluorogenic peptide 
substrates targeted to different organelles can then be rapidly synthesized by “click” 
chemistry. Upon substrate recognition and protease cleavage in the respective 
organelles, the SG2-conjugated localization peptide will be released, leading to a 









Figure 3.1. Overall strategy for imaging protease activity in subcellular organelles. 
Fluorogenic peptide substrates targeted to different organelles are assembled of individual 
protease substrates and localization peptides by “click” chemistry. Protease cleavage results 





































The primary objective in this work is to demonstrate the feasibility of using 
short peptide localization sequences to deliver fluorogenic peptide substrates to 
particular subcellular organelles for the detection of localized protease activity 
through fluorescence imaging. As a model system, we decided to use the induction of 
apoptosis to bring about the activation of caspases, which are known to be specific 
proteases [13]. Central to apoptotic events are the translocation and activation of pro-
caspases upstream apoptotic mediators [58]. This results in further translocation of the 
caspases and/or the cleavage of substrates localized exclusively in a particular 
organelle, leading eventually to cell demolition. While the subcellular localization of 
caspases remains controversial arising from the use of different cell lines and 
apoptosis inducers, several key observations are consistent in the literature surveyed. 
The nuclear [59] and mitochondrial [60] localization of pro-caspases and caspases is 
well-established by subcellular fractionation and western blotting. It is thus 
imperative that we evaluate the utility of our approach in detecting caspase activity in 
the mitochondria and nucleus. Expanding on our previous imaging experiments with 
Ac-DEVD-SG1, we selected a few protease substrates that target proteases which 
were involved in apoptosis and/or are activated by external stimuli. We selected 3 
caspase substrates, including the substrate for caspase-3 and -7 which has often been 
used for imaging apoptosis, as well as substrates for caspase 2 and caspase 9.  
 
We are also interested in other proteases such as the cysteine protease 
cathepsins which are localized exclusively to the endosomes, and in particular 
cathepsin B which is known to have a role in apoptosis [61]. The last peptide substrate 
that we picked is that for µ-calpain and m-calpain, which are activated in the presence 
of micromolar and millimolar concentrations of calcium respectively, within the cell 
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[62]. In addition, these calcium-dependent proteases are also involved in apoptosis 
[63]. By selecting caspases, cathepsins and calpains as our target enzymes, we could 
potentially study these cysteine proteases in synergy with our platform. The list of 
peptide substrates, their target proteases and the known subcellular localizations of the 
proteases are summarized in Table 3.1 below.  
 
 Peptide Target Enzyme(s) 
SG2-(a) Ac-DEVD-SG2-alkyne Caspase-3/-7 substrate 
SG2-(b) Ac-VDVAD-SG2-alkyne Caspase-2 substrate 
SG2-(c) Ac-LEHD-SG2-alkyne Caspase-9 substrate 
SG2-(d) Ac-FR-SG2-alkyne General cathepsin substrate 
SG2-(e) Ac-FRR-SG2-alkyne Cathepsin B substrate 
SG2-(f) Ac-LLVY-SG2-alkyne Calpain I/II substrate 
 
Table 3.1 Alkyne-functionalized SG2-based substrates and their target enzymes 
 
To deliver these fluorogenic substrates to the desired subcellular compartment, 
we surveyed the literature for short peptide sequences that have been shown to 
localize specifically or function as efficient carriers of various cargo types to a 
particular organelle. A well-established peptide carrier is the Simian virus 40 (SV40) 
T-antigen nuclear localization signal (NLS) which has been used to deliver proteins 
and peptide substrates to the nucleus [64]. Another important organelle is the 
mitochondria which serves to produce the cell’s energy and as a checkpoint regulating 
apoptosis. In recent years, a plethora of delivery modes and targeting modules specific 
for the mitochondria has emerged. A systematic study elucidating the molecular 
requirements in designing synthetic peptides that exhibit efficient cellular uptake and 
can penetrate the mitochondria was recently carried out by the Kelley group [65]. In 
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the same study, the group identified a cationic, lipophilic peptide containing 
cyclohexane and arginine residues which were cell-permeable and mitochondria-
specific, which would serve our purpose as a mitochondria-targeting localization 
sequence. We further used an N-palmitoylated lysine residue to mimic a common 
post-translational modification that several membrane proteins undergo for trafficking 
to the plasma membrane [66]. The localization sequences used and their target 
organelles are summarized in Table 3.2 below. In addition, we included two cell-
penetrating peptides (CPPs), also known as protein transduction domains (PTDs) as 
general modes of delivery into the intracellular space. These short peptide sequences 
are known to promote the cellular intake of small molecules, quantum dots and even 
proteins which would otherwise be cell-impermeable. The sequences of the 
localization peptides selected are summarized in Table 3.2 below. 
 
ID Peptide Target Organelle 
N3-SV40 N3-KKKRKV-NH2 nucleus 
N3-RrRK N3-RrRK-NH2 nucleus 
N3- FxrFxK N3-FxrFxK-NH2 mitochondria 
N3-KK N3-KK(palmitoyl)-NH2 membrane 
N3-Tat N3-RKKRRQRRR-NH2 general CPP, nucleus 
N3-R9 N3-RRRRRRRRR-NH2 general CPP 
 
Table 3.2 Azide-functionalized localization peptides selected and their target organelles 
 
To evaluate whether these localization sequences indeed localize to the correct 
organelle, we labeled the peptides with SG2 to form SG2-peptide conjugates whose 




3.3 Chemical Synthesis of Peptide Substrates and Localization Peptides 
 
3.3.1 Chemical Synthesis of Alkyne-Tagged Peptide Substrates 
 
The key considerations in designing the synthetic routes to our peptide 
substrates are i) the placement of the various functional groups (fluorogenic peptide 
substrate and alkyne handle) and ii) adapting the synthesis on solid phase for facile 





















Scheme 3.1 Synthesis of Fmoc-SG2-COOH (3-1) and Fmoc-SG2-COCl (3-2) 
 
In our synthetic strategy, we decided to transform SG2 into an Fmoc-protected 
unnatural amino acid to enable conventional solid-phase peptide synthesis using Fmoc 
chemistry, which has already been demonstrated to be suitable chemistry for the 
fluorophore. SG2 was first protected with Fmoc as described in Chapter 2.3.2 and the 
alcohol moiety was oxidized to the acid Fmoc-SG2-COOH (3-1) using standard 
oxidation procedures with PDC (Scheme 3.1). The acid group could serve as a point 
of attachment to the solid support and also to an alkyne moiety for “click” chemistry 
with azide-conjugated localization sequences. To this end, we started solid-phase 
synthesis with the reductive amination of the aldehyde-functionalized PL-FMP 
(polystyrene – 4-formyl-3-methoxyphenoxy resin) with propargyl amine to give a 
secondary amine. This was followed by the acylation with Fmoc-SG2-COOH which 
would result in the simultaneous loading of the Fmoc-protected dye onto the solid 
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support and tagging with an alkyne handle. Several conditions were tried to effect the 
coupling reaction between Fmoc-SG2-COOH and the resin-bound secondary amine. 
Both overnight reaction using HBTU/HOBt and the stronger coupling reagent 
PyBrOP failed to load the compound onto the solid support. This was evidenced from 
the product that was cleaved from the solid support after Fmoc deprotection and 
coupling of the Fmoc-Asp(OtBu)-OH using HBTU/HOBt. Instead of obtaining the 
desired Fmoc-Asp-SG2-alkyne, Fmoc-Asp-alkyne was obtained in good purity, 
indicating that the acylation reaction between Fmoc-SG2-COOH did not take place. 
Since the same reaction worked well for Fmoc-Asp(OtBu)-OH, it is unlikely that the 
coupling conditions were not strong enough when Fmoc-SG2-COOH was used. We 
reasoned that a possible reason why the desired acylation reaction did not occur was 
the degradation of Fmoc-SG2-COOH via the cyclization of the linker to form a γ-











Figure 3.2. a) Attempted attachment of Fmoc-SG2-COOH by acylation of Fmoc-SG2-COOH 
and resin-bound secondary amine using various coupling reagents. b) Possible cyclization of 
linker moiety on Fmoc-SG2-COOH under basic conditions. 
 
To prevent this side reaction, Fmoc-SG2-COOH was converted into the 
corresponding acid chloride using oxalyl chloride with catalytic DMF (Scheme 3.1). 


















OFmocN O- OFmocHN O
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which resulted in the successful loading of Fmoc-SG2-COOH onto the solid support. 
Following Fmoc deprotection of resin-bound SG2, standard solid phase peptide 
synthesis was carried out employing Fmoc chemistry to furnish the desired peptide 

































Scheme 3.2. Solid-phase synthesis of alkyne-functionalized substrates, Ac-X-SG2-alkyne. a) 
NaBH3CN, DMF/MeOH/AcOH (8:1.9:0.1), 16 h; b) Fmoc-SG2-COCl (3-2), DIEA, CH2Cl2, 12 h; 
20% piperidine/DMF, 30 min; d) Ac2O, DIEA, CH2Cl2, 3 h; e) TFA/H2O/TIS (95:2.5:2.5), 2 h. 
 
The N-terminus of the peptide was capped with an acetyl group by reaction with 
acetic anhydride. Cleavage from the solid support with concomitant deprotection of 
the side chain protecting groups using TFA/H2O/TIS was carried out to obtain the 
desired alkyne-tagged peptide substrates which were characterized by LC-MS 
analysis. In all 6 peptide conjugates, 2 major peaks were found, one corresponding to 
the desired product (abbreviated Ac-X-SG2-alkyne, X is the peptide sequence) and 
the other corresponding to the peptide sequence directly conjugated to the alkyne 
without SG2 (Figure 3.3a). The occurrence of this product indicates that the acylation 
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of the acid chloride of Fmoc-SG2-COOH and the secondary amine was not complete, 
possibly due to the steric bulk of the dye and the high loading level of the resin (0.9 
mmol/g).  
 










































































Ac-X-SG2-alkyne, X = peptide Ac-X-alkyne, X = peptide
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3. Ac-LEHD-SG2-alkyne 

























































































Figure 3.3. a) General structures of the 2 products found corresponding to the 2 major peaks 
in the LC profiles. The major side product resulted from the direct acylation of the first Fmoc-
AA-OH onto the resin-bound secondary amines which did not react with Fmoc-SG2-COCl. b) 
LC-MS profiles of the 6 synthesized Ac-X-SG2-alkyne. LC conditions: 30-100% CH3CN in 15 
min. 
 
3.3.2 Chemical Synthesis of Localization Sequences 
 
 Synthesis of the localization sequences was straightforward, using standard 
solid-phase peptide synthesis on Rink amide with Fmoc chemistry. After peptide 
elongation, the N-terminus of each peptide is capped with either 4-azidobutanoic acid 
to install an azide or acylated with the acid chloride of Fmoc-SG2-COOH as 
described in Chapter 3.3.1 to obtain a dye-peptide conjugate. This latter series of 
peptides will be referred to as the “control peptides”. Synthesis of the localization 
sequence 4 followed a different route due to the need for attachment of the palmitoyl 
group.  The Rink amide resin was first coupled with Fmoc-Lys(Mtt)-OH followed by 
Fmoc deprotection and Fmoc-Lys(Boc)-OH. Deprotection of the terminal Fmoc group 
followed by acylation with 4-azidobutanoic acid or Fmoc-SG2-COOH gave the 
* 
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respective N-capped dipeptides. The extremely acid-labile Mtt group was selectively 
cleaved in the presence of the Boc group with 1% TFA and 5% TIS, exposing a free 
amine for coupling with palmitic acid. For the azide-functionalized localization 
peptide, the desired lipid-modified dipeptide was obtained directly by cleavage from 
the solid support using standard cleavage conditions, while the control peptide 4 
required an additional Fmoc deprotection step before cleavage. LC-MS analysis for 
the azido-peptides showed that the desired peptide was obtained in good purity (single 
LC-MS peak). The SG2-conjugated control peptides however, showed more 
impurities especially for the 2 CPPs. During the acylation step with Fmoc-SG2-
COOH (in both the synthesis of the control peptides and the peptide substrates), it was 
found that the excess acid chloride could not be washed off easily. A washing cocktail 
of 1% TFA/DCM was found to be effective in removing most of the excess reagent, 
but this washing procedure was apparently less effective for the longer peptides, as 
evidenced by the appearance of several other peaks which showed strong absorbance 
in the 490 nm channel, which is approximately at the absorbance peak of the 
fluorophore. 
a) 
i) N3-KKKRKV-NH2 (LC conditions: 0-50% ACN in 15 min) 



















ii ) N3-RrRK-NH2 (LC conditions: 0-50% ACN in 15 min) 



















iii )N3-FxrFxK-NH2 (LC conditions: 25-100% ACN in 15 min) 





















iv) N3-KK(palmitoyl)-NH2 (LC conditions: 50-100% ACN in 15 min) 

















v) N3-RKKRRQRRR-NH2 (LC conditions: 0-50% ACN in 15 min) 






















vi) N3-RRRRRRRRR-NH2 (LC conditions: 0-50% ACN in 15 min) 



























































































































Figure 3.4. LC-MS profiles of a) azido-localization peptides; b) control peptides 
 
 
3.4 Bioimaging of Control Peptides 
 As a preliminary examination of whether the localization sequences can act as 
carrier modules, we synthesized dye-peptide conjugates to enable us to visualize the 
intracellular locations of these conjugates. Trackers that mark a specific organelle 
were used to determine if the conjugates have the intended localization. MCF-7 and 
HeLa cells were used for imaging as these are well-studied cell lines in which the 
localizations of some of the conjugates have been experimentally determined (with 
the use of other dyes instead of SG2). The SV40 and RrRK localization sequences 
were found to be toxic to HeLa cells at a concentration of ~ 10 µM as evidenced by 
the change in cell morphology after 1 h of incubation with the peptide. The 2 




































Control peptide (GFP) Organelle Tracker (RFP) Overlay 
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Figure 3.5. Fluorescent images of control peptides and corresponding organelle stains. a) 
MCF7 cells; b) HeLa cells. The following organelle stains were used for the corresponding 
peptides: FxrFxK – MitoTracker® Red; KK(palmitoyl) – CellMaskTM Orange; Tat and R9 – 
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Fluorescence images of the control peptides showed that the mitochondria- and 
membrane-targeting peptides localize as expected in both HeLa and MCF7 cells, but 
the two CPPs, Tat and R9 show mostly endosomal localization, with the exception of 
the Tat control peptide in HeLa cells, which shows some nuclear localization. In these 
initial experiments, we could not achieve nuclear targeting of the dye-peptide 
conjugate uniformly throughout the cells under observation. It is a well-known 
problem that these CPPs tend to localize in different organelles of the cell, depending 
on various factors such as the type of cell line, the cargo and the uptake conditions 
[67]. Endosomal entrapment of cargo resulting from CPP-mediated cellular uptake is 
common, resulting in inefficient delivery of the cargo to its intended location. This in 
part gives us a tool to effectively deliver CPP-conjugated protease substrates 
(targeting the cathepsins, for example) to the endosomes and the lysosomes if they 
remained trapped in the vesicles. Nuclear targeting however, may be achieved 
through optimizing uptake conditions, using other nuclear localization sequences, or 
more effectively, the use of methods enabling endosomal escape. 
 
 While these imaging experiments act as controls to ensure that the intended 
localizations are achieved, they do not necessary imply that subcellular delivery of the 
peptide remains unchanged when conjugated to another peptide. This is due to the 
alteration of the overall charges and lipophilicity of the localization peptide, which 
may affect localization to certain organelles. The mitochondria-penetrating peptide, 
for example, relies on a balance of cationic charges and lipophilicity for permeating 
the charged membrane and entry into the hydrophobic intermembrane space. Because 
the mechanisms of entry into the cell and the mitochondrial membrane are not well 
understood, the attachment of charged peptides could lead to an unpredictable change 
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in localization. Our studies in this chapter will elucidate whether these relatively 
unexplored localization peptides (FxrFxK, KK(palmitoyl)) can be used as general 
targeting modules for peptides. 
 
3.5 Current Work 
 
 Our initial bioimaging experiments with the localization peptides showed that 
we could successfully deliver the peptides to the mitochondria, plasma membrane and 
the endosomes or lysosomes, but not efficiently to the nucleus. We are currently 
working on optimizing the conditions for the cellular uptake of the 2 general CPPs, as 
well as the SV40 NLS, which has been used as a delivery vehicle for peptide 
sequences. An alternative is to enable direct membrane translocation of the 
localization peptide, instead of through endocytosis which plays a major role in 
cellular uptake. Futaki’s group has shown that negatively charged, highly 
hydrophobic molecules can alter the electronic properties of oligoarginines through 
electrostatic interaction such that the pathway to cellular internatlization is altered 
[68]. The group subsequently showed that pyrenebutyrate mediated the delivery of a 
fluorescently-labeled octaarginine peptide directly into the cytosol and nucleus in 
HeLa cells [69]. This may be a potential solution to achieve direct cytosolic / nuclear 
delivery of our CPPs. An alternative is to micro-inject the NLS into the cell, which 
also evades the problem of endosomal entrapment. Further to the problem of the use 
of these CPPs is the cellular toxicity of these highly charged, cationic peptides still 
remains an important issue to be addressed. Specifically, we need to determine the 
concentration at which the peptides become cytotoxic. 
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 We have also completed the solid-phase synthesis of the azide-functionalized 
localization peptides and the SG2-based peptide substrates targeting various cysteine 
proteases. To further optimize the synthetic procedures described herein, Fmoc-SG2-
COCl may be used in larger molar ratio (4 equiv instead of 2.5) to drive the acylation 
reaction with the resin-bound secondary amine to completion. In addition, an 
additional capping step with acetic anhydride to consume the unreacted secondary 
amines will prevent the formation of the peptide substrate without conjugation to SG2. 
This should give a higher yield and purity for each peptide. Currently, with the 
exception of SG2-LLVY-alkyne which needs further purification, the alkyne-
substrates can be used directly for click chemistry with the azido-peptides  as they are 
sufficiently pure for the reaction to be monitored by LC-MS. We are currently 
optimizing the conditions for the “click” assembly of the different peptide 
components to furnish the final targeted peptide substrates. 
 
 Several experiments have also been designed which could give a preliminary 
evaluation of our approach in live-cell fluorescence imaging of protease activity in 
subcellular compartments. The proof-of-concept experiments will begin with 
incubating either HeLa or MCF7 cells with the cathepsin substrates (Ac-FRR-SG2 or 
Ac-FR-SG2) and observing the fluorescence image. Since the target lysosomal 
cysteine proteases are constitutively active, we should detect fluorescence outputs 
localized in the endosomes / lysosomes, which may be detected using the organelle 
tracker, LysoTracker®. Addition of general cysteine protease inhibitors, such as E-64, 
should lead to a fluorescence decrease.  
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To study caspase activity, we will incubate HeLa cells with Ac-DEVD-SG2-
FxrFxK and Ac-DEVD-SG2-Tat followed by apoptosis induction using staurosporine. 
If caspase activity is present in the corresponding organelles, we should observe a 
fluorescence increase after induction resulting from caspase cleavage of the substrate. 
The localization of this fluorescence increase should correlate well with organelle 
trackers that are known to be highly specific. Again the fluorescence increase should 
be significantly suppressed by the addition of either pan-caspase inhibitors, such as 
zVAD-fmk, or inhibitors specific for caspase-3/-7. 
 
 Similar experiments for the study of calpain activity are also planned. The 
external stimulus is the calcium ionophore, ionomycin, which activates calpain I and 
II. Cells loaded with the targeted peptide substrates Ac-LLVY-SG2-Tat or Ac-LLVY-
SG2-KK(palmitoyl) should display fluorescence increase in the nucleus and plasma 
membrane respectively after calcium induction. The addition of calpastatin peptide 
(specific calpain I/II inhibitor) prior to calcium induction will serve as a positive 
control, similar to the experiments for cathepsins and caspases. 
 
 We are also looking at the possibilities of multiplexed imaging – detecting 
protease activity in different organelles in the same cell, and/or imaging different 
proteases simultaneously. This would be useful in systems where there is significant 
cross-talk between the different classes of proteases in a biological event. Apoptosis, 
for example, involves the caspases, as well as the calpains and cathepsins, with each 
different class contributing to (or in some cases, inhibiting) the apoptotic cascade. It 
will therefore be useful to develop tools that enable the real-time imaging of different 
critical proteolytic events. Multiplexing may be accomplished by the using 
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fluorogenic peptides that can be detected at a different fluorescence channel, for 
example, the blue DAPI channel. A candidate fluorophore would be ACC, since the 
synthesis of ACC-based peptide substrates are well-established and can readily be 
adapted to our strategy.  
 
 The aim of the current work presented herein is to establish a previously-
unexplored platform for the real-time imaging of protease activity localized in distinct 
organelles in live cells. This platform will be complementary to well-established 
methods of detecting proteins such as immunofluorescence and subcellular 
fractionation followed by western blotting. Our approach also carries the advantage of 
imaging protease activity which is directly correlated to its function, instead of merely 














CHAPTER 4 DISCOVERY AND DEVELOPMENT OF FLUOROGENIC 
LABELS FOR BIOMOLECULES 
 
 
4.1 Fluorogenic Labeling of Biomolecules 
 
The green fluorescent protein (GFP) has become an invaluable tool in 
molecular and cell biology since its inception about 15 years ago as a tool for 
fluorescently tagging proteins of interest in their native environments [70]. 
Accompanied by parallel advances in imaging technologies, the fluorescent protein 
toolbox has expanded with the inclusion of variants of various fluorescing 
wavelengths that span the visible spectrum and with different applications. Genetic 
fusion of the fluorescent protein (FP) tag to the protein of interest ensures that 
labeling is specific to the protein under study, but offers no control over when and 
where visualization of the protein is most desired. This lack of spatiotemporal control 
for the study of protein dynamics has led to the development of other imaging 
techniques, such as fluorescence recovery after photobleaching (FRAP) and 
fluorescence loss in photobleaching (FLIP) which involve the eradication of 
fluorescence in a region of interest by intense laser illumination. With increasing 
sophistication in imaging technologies, there is growing interest in photoactivatable, 
photoconvertible and photoswitchable FPs, collectively termed as optical highlighters 
[71], in which the fluorescence of the FP can be turned on or shifted to another region 
of the visible spectrum by light. These “highlighters” create a distinct population of 
proteins for selective visualization and the study of protein dynamics [72].  
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Despite these advances, the major drawback using FPs as a means of 
visualizing proteins lies in their size – the modification with a large (~ 27 kDa) 
protein tag by genetic fusion inevitably has the potential problem of interfering with 
the endogenous function of the protein. In addition, the optical and physical properties 
of FPs which are photoresponsive that have been developed so far still fall short of 
being optimal for routine usage in imaging experiments. There is clearly a need for 
alternative approaches that could give the experimenter direct control over the 
labeling event. 
 
In recent years, a new dimension to protein labeling has emerged with the 
advent of using small molecule tags for site-selective protein modification [73]. The 
seminal work published by Tsien and co-workers in 1998 describes the specific 
covalent labeling of enhanced cyan fluorescent protein (ECFP) genetically fused with 
a tetracysteine peptide binding motif employing a biarsenical fluorescein analog as 
the ligand [74]. Known as the FlAsH (Fluorescein Arsenical Helix binder) ligand, the 
authors successfully demonstrated the occurrence of FRET between ECFP and FlAsH 
in live mammalian cells. This work was significant in a number of ways. It was the 
first example of using a small-molecule ligand to label a protein at a specific site in an 
in vivo setting. This allowed temporal control of the labeling event, a major advantage 
over genetically encoded FP tags. In addition, modification of the protein of interest 
by a short peptide instead of a large FP considerably alleviated the problem of 
functional interference caused by the tag. Tsien’s group further introduced the red- 
and blue-fluorescing versions of FlAsH, ReAsH and ChoXAsH respectively, and 
optimized the peptide motif for increased binding affinity to the biarsenical ligands 
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[75, 76].  These findings collectively set the direction for future developments in the 
field of in vivo protein labeling.   
 
A recent trend in the field of protein labeling is the use of fluorogenic dyes 
which register a dramatic increase in fluorescence upon non-covalent or covalent 
interaction with the protein of interest. The advantage conferred by these dyes is clear 
– these molecules serve as self-reporting indicators of the binding or labeling event 
and the background fluorescence contributed by unbound or unreacted dyes is kept to 
a minimum. This is particularly important in bioimaging as it leads to a higher signal-
to-noise ratio which translates to the more sensitive detection of cellular proteins, 
especially less abundant proteins. This concept was in fact first demonstrated by the 
FlAsH family of biarsenical ligands which fluoresce strongly only upon binding to the 
tetracysteine motif but not when it is a bis 1,2-ethanedithiol (EDT) adduct, the form 
which is used for labeling. However the de novo design of these dyes is not trivial and 
requires substantial experimentation.  Though there are notable examples of novel 
fluorogenic dyes, the majority of the fluorogenic labels to date rely on the appendage 
of other functional groups such as fluorophore quenchers to confer latent spectral 
properties which are activated upon labeling. 
 
Fluorogenic labels for biomolecules developed to date may be classified into 
two categories: i) structurally new fluorogenic dyes and ii) an internally quenched 
fluorophore where the quenching mechanism is inactivated during the labeling 
reaction. The fluorescence activation is typically initiated by light or by a highly 
specific reaction, both of which result in a covalent bond between the dye and the 
biomolecule. One of the most prominent examples in the former category is the 
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family of “click” coumarins reported independently by the Wang and Fahrni groups. 
[77] The two groups introduced the concept of fluorogenic “click” reactions in which 
a weakly fluorescent azido- or alkyne-coumarin is converted into a fluorescent 
molecule by triazole formation using a Cu(I)- catalyzed azide-alkyne cycloaddition, 
more commonly known as “click” chemistry. This unique feature, coupled with the 
bioothorgonal nature of the cycloaddition reaction, has found useful applications in 
the fluorescence labeling and visualization of glycans [78], newly synthesized 
proteins [79] and lipids [80]. However, the need for the toxic Cu(I) has limited the use 
of this fluorogenic bioconjugation method in bioimaging to fixed cells, thereby 
excluding it from the study of protein dynamics.  A potential improvement of the 
fluorogenic “click” reaction was presented by Lin and co-workers who utilized a 
photoinduced 1,3-dipolar cycloaddition reaction between an in situ formed nitrile 
imine from a tetrazole precursor and an alkene, termed as “photoclick chemistry”. The 
pyrazoline adduct formed was fluorescent, allowing the reaction to be monitored by 
the fluorescence readout. The authors successfully demonstrated the use of this 
fluorogenic reaction in functionalizing a protein with a genetically incorporated O-
allyl tyrosine residue in live bacterial cells [81].  
 
Another approach to fluorogenic labeling relies on the use of fluorescence 
quenching systems in which the fluorophore remains spectrally silent until the 
quenching mechanism is disengaged when labeling occurs. The Bertozzi group first 
developed a coumarin-phosphine dye whereby the lone pair of electrons quenches the 
excited state of the coumarin fluorophore [82]. Phosphine oxidation eliminates 
quenching, leading to a dramatic fluorescence increase. This oxidation reaction was 
brought about by Staudinger ligation of the coumarin-phosphine to an azide-
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functionalized protein, such that labeling of the protein was accompanied by a 
fluorescence increase. However, non-specific auto-oxidation of the phosphine group 
reduced ligation efficiency and fluorescence output. To overcome this problem, the 
group recently developed a FRET-based fluorogenic phosphine attached to 
fluorescein in which a quencher is released upon ligation with an azide, thereby 
releasing the fluorescence [83]. This design allows for the incorporation of different 
dye / quencher pairs for multicolor labeling. While applicable to live-cell imaging, the 
Staudinger ligation has slower reaction kinetics than “click” chemistry, thus limiting 
its dynamic range of usage. 
 
The abovementioned examples utilize a highly specific bioorthogonal 
chemical reaction for labeling with concomitant fluorescence increase. Another 
contribution in the development of fluorogenic labeling is the use of enzymatic 
reactions to label a protein with a fluorogenic probe. Kikuchi and co-workers 
designed a β-lactam FRET probe that is catalytically trapped by a mutant β-lactamase, 
and demonstrated the labeling of a membrane-associated protein fused to the enzyme 
in live cells [84]. In a different approach, the groups of Bogyo [85] and Nagano [86] 
used quenched and FRET activity-based probes (ABPs) respectively to specifically 
label and visualize their target enzymes. With the development of these probes, it is 
likely that future ABPs will be designed for use in bioimaging applications, a 
direction which is previously unexplored in the field of enzyme profiling by ABPs. 
 
A brief survey of fluorogenic labeling methods reveals the need for the 
development of new fluorogenic reagents and the improvement of current ones to 
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enable a broad range of bioimaging applications. This chapter deals with our approach 
in our search of fluorogenic labels – fluorescence activation by “click” chemistry. 
 
4.2 Combinatorial Discovery of Fluorophores 
 
Small organic dyes and fluorescent probes are well-established labeling agents 
and sensors in both chemical and biological systems [86]. Despite their wide-ranging 
applications and popularity in reporter assays and visualization tags, the underlining 
photophysical properties of some of these dyes in relation to their molecular structures 
are not yet well understood. Consequently, the rational design of novel fluorophores 
possessing highly predictable and desirable properties has remained elusive. The lack 
of well-defined rules to govern fluorophore design has driven combinatorial efforts in 
fluorophore discovery in recent years [87]. These efforts have been aided by the use 
of novel synthetic methodologies to construct novel fluorophore cores [88]. However, 
fluorophore discovery is often not the end purpose in these cases but rather a 
serendipitous finding in the process of developing synthetic methodologies.  A more 
directed, systematic approach to combinatorial fluorophore synthesis is the 
modification of core structures from known fluorophores to furnish analogs of the 
parental molecules. This has thus far led to the discovery of new fluorescent 
molecules with a range of spectroscopic properties.  
 
One notable method for the rapid discovery of fluorophores is the use of the 
Cu(I)- catalyzed azide-alkyne cycloaddition, the representative reaction in “click” 
chemistry [89], to assemble a variety of structurally-related fluorophores. The Wang 
and Fahrni groups independently introduced the concept of fluorogenic “click” 
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reactions in which a weakly fluorescent azido- or alkyne-coumarin is converted into a 
fluorescent molecule by triazole formation using “click” chemistry [77]. At present, 
only the coumarins [77], carbostyrils [90], anthracenes [91], naphthalimides [92] and 
pyridyloxazole [93] mimics comprise the family of “click” fluorophores in which 
“click” chemistry has been used as a fluorogenic reaction and/or for diversification to 




























Figure 4.1. Fluorophore types which have been synthesized using “click” chemistry 
 
One major drawback of the current “click” fluorophores is that all of them are UV-





























































cells or tissues are used. The key aim in the current work is twofold. We wish to 
extend the “click” chemistry-mediated discovery of fluorescent dyes to previously 
unexplored fluorophore scaffolds, especially those with excitation wavelengths in the 
visible range. In addition, we hope to find new scaffolds that can be used as 
fluorogenic labeling reagents for bioimaging applications.  
 
4.3 Design of Xanthone- and Xanthene-based “Click” Fluorophores 
 
Recently, our group introduced a new fluorophore, Singapore Green [22], a 
structural hybrid of Tokyo Green (a fluorescein analog) [37] and Rhodamine 110 with 
similar emission and excitation properties to both (Figure 4.2). We reasoned that 
replacement of the oxygen electron donor at the 6’ position with an alkyne in both 
Singapore Green and Tokyo Green will significantly decrease the fluorescence output 
of their xanthene core. We further extended this design to Rhodamine B by similarly 
substituting the diethylamino group at the 6’-position with an alkyne, as well as 
replacing the carboxylic acid moiety in Rhodamine B with a methyl group at the 2-
position to lock the xanthene core in the conjugated quinol-iminium form. We 
anticipate that the formation of a triazole ring at this position using “click” chemistry 
will result in a fluorescence change in these xanthene-alkynes through an extended pi- 
conjugated system, and that this change can be tuned by the use of azides with 
different electronic properties. In the interest of extending the emission range of our 
“click” fluorophores from blue to the yellow region, we also used the blue-light 
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Figure 4.2. Design of xanthone- and xanthene-based “click” fluorophores from known 
fluorophores. 
 
Similar to the design of our xanthene-alkynes, we replaced the heteroatom at 
the 6-position with an alkyne to yield the xanthone-alkyne for “click” modification. 
We noted that while there are several reports on the synthesis and spectroscopic 
characterizations of rosamine dyes from 3,6-disubstituted xanthones [93, 94], to the 
best of our knowledge there are no  detailed studies on xanthone-based fluorophores 
and their fluorescence properties.  
 
4.4 Chemical Synthesis of Xanthone- and Xanthene-based “Click” Fluorophores 
 
4.4.1 Chemical Synthesis of Xanthone- and Xanthene-Alkynes and Azides 
 
The general synthetic strategy for the alkynes A, B, D and E involves the 
desymmetrization of the common starting material 3,6-dihydroxyxanthone 4-1 to give 
the appropriate substituent at the 6-position, leaving the other phenolic group for 
conversion into a triflate which serves as the substrate for Sonogashira coupling with 
trimethylsilylacetylene. Deprotection of the TMS group affords alkynes A and B, 
while Grignard addition to the xanthone followed by removal of the protecting groups 
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Scheme 4.1. General synthetic strategy towards alkynes A, B, D and E. 
 
To synthesize 4-2a, 4-1 underwent monomethylation in the presence of 1 equiv of 
K2CO3 which acts as a base to deprotonate the phenol followed by conversion into a 
triflate. 4-2b was synthesized by direct substitution of the ditriflate formed from 4-1 
(Scheme 2.2) with diethylamine. As reported in recent literature [27], the presence of 
an electron-withdrawing carbonyl group in the para position activates the triflate 
group towards nucleophilic aromatic substitution, making this reaction feasible under 
conditions that are milder than normally required for similar reactions in other 
substrates. The reactivity of the xanthone unit is considerably reduced after mono-
substitution as the electron-donating diethylamino moiety deactivates the ring.  A 






























Scheme 4.2. Synthesis of 4-2a and 4-2b from 1 
 
disubstituted product 4-2bi. Attempts to install the alkyne moiety by direct 
nucelophilic substitution of the second triflate by sodium acetylide were unsuccessful, 
giving compound 4-2bii instead. The triflate group was removed during the reaction, 
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probably due nucleophilic attack at the sulfur atom instead of the sp2 aromatic carbon. 
In a separate experiment, the reaction between 4-1ii and NaN3 in DMSO at 70οC  
similarly led to the removal of one triflate group.  In the reaction with diethylamine, 





















































Figure 4.3. Undesired products obtained during the nucleophilic aromatic substitution of 2b 
and 1ii with different nucleophiles. a) Mechanism of nucleophilic attack leading to a formal 
hydrolysis of the triflate. b) Formation of undesired phenols with sodium acetylide and NaN3 
as nucleophiles. c) Various products observed from the prolonged reaction of 1ii and 
diethylamine. 
 
A possible explanation for this pattern of reactivity lies in the nucleophilicity 
of the attacking species; the acetylide and azide anions which are charged and 
unhindered, are strong nucleophiles compared to diethylamine which is neutral and 
relatively more hindered.  These nucleophiles can attack the more hindered sulfur 
atom in the triflate group to displace the phenoxide anion as the leaving group. 
Consequently alkynes 4-3a and 4-3b had to be synthesized by Pd(0)-catalyzed 
Sonogashira coupling in the presence of CuI. 
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The synthesis of alkynes C and F followed a strategy similar to that employed 
for alkynes A, B, D and E. Starting from 3-nitro-6-hydroxyxanthone 4-4, it was 
converted to triflate 4-5 which underwent Sonogashira coupling to give the TMS-
protected nitroxanthone 4-6 (Scheme 4.3). The nitro group was reduced under mild 
conditions to aniline 4-7 with zinc in MeOH/THF buffered at pH 5. Under these 
conditions, the labile TMS group was preserved. Aniline 4-7 was protected with a 
trityl protecting group, followed by Grignard addition to give the trityl-protected 
xanthene 4-9. Subsequent deprotection of the trityl and TMS groups furnished the 



















































Scheme 4.3. Synthesis of alkynes C and F. 
 
 The azides used in the study were selected from a panel of azides previously 
synthesized and reported by our group. To investigate the influence of the electronic 
properties on the azides on the fluorescence properties of the fluorophores, both 
electron-rich and electron-deficient aromatic azides were used, including halogenated 
and heterocyclic azides. A few structurally different aliphatic azides were used as well 
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to test if peripheral groups that are electronically decoupled from the fluorophore core 
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Figure 4.4 Structure of the azides used in this study. 
 
Aromatic azides that were not previously by our group were synthesized by a simple 
diazotization reaction of the precursor aniline followed by substitution by NaN3 as 









Scheme 4.4 Synthesis of aromatic azides from anilines 
 
A total of 17 azides were picked for the Cu(I)- catalyzed [3 +2] cycloaddition with the 




































Scheme 4.5. “Click” Assembly of Fluorophores 
 
With the 6 alkynes and 17 azides in hand, we assembled the fluorophore 
library in a 384-deep well block by mixing each of the alkynes with a different azide 
in DMSO/tBuOH/H2O to give a unique pair of alkyne and azide in each well. The 
“click” reaction was slow when CuSO4 and sodium ascorbate which generated the 
active Cu(I) species were used in sub-stoichiometric amounts (0.2 and 0.5 equiv 
respectively) in several solvent combinations such as tBuOH/H2O and DCE/H2O, 
such that very little or no product was formed after 24 h. We then tried a combination 
of CuSO4 (2 equiv) and sodium ascorbate (5 equiv) for the reaction. Under these 
conditions, the “click” reaction for the xanthene-alkynes D-F proved to be highly 
efficient, with the alkynes consumed within 12 h to give the products in high purity as 
monitored by LC-MS. The xanthone-alkynes A-C were considerably less reactive 
with some incomplete reaction after 12 h. The desired product was obtained for all 
compounds with the exception of products with azides z13 and z14 which did not give 
the desired products for all the alkynes and were thus omitted from subsequent studies. 
LC-MS analysis was carried out on the entire library to ensure that the library is of 

























































































































































































































































































































































227.15 954.75361.15 537.30 700.10 856.85
 
 
Figure 4.5. LC-MS profiles of selected “click” fluorophores. LC conditions: 30-100% (alkynes 
A-C) or 20-100% (alkynes D-F) ACN in 10 min . * - unconsumed alkyne; ** - no MS found for 
peak, assumed to be excess azide 
 
 
4.5 Spectroscopic Analysis of the “Click” Fluorophore Library 
 
For preliminary evaluation of the fluorescence properties of the library, the 
crude reaction mixture was diluted to 400 µM in DMSO, which was further diluted to 
20 µM for fluorescence screening. Since the quantum yield of fluorophores can be 
significantly influenced by solvent effects, we chose four different solvents – H2O 
(aqueous, with DMSO as cosolvent to prevent precipitation), DMSO (polar aprotic), 
EtOH (polar protic) and DCE (apolar aprotic) to record the excitation and emission 
spectra of all the fluorophores in the library. The excitation and emission maxima for 







Solvent Max λex Max λem Solvent Max λex Max λem Solvent Max λex Max λem
A 326 429 B 389 471 C 362 487
A-z1 362 495 B-z1 389 465 C-z1 365 472
A-z2 368 489 B-z2 386 462 C-z2 362 481
A-z3 365 522 B-z3 386 453 C-z3 356 469
A-z4 356 435 B-z4 386 453 C-z4 365 481
A-z5 347 438 B-z5 389 459 C-z5 362 478
A-z6 347 447 B-z6 383 468 C-z6 362 478
A-z7 332 444 B-z7 386 468 C-z7 356 475
A-z8  -  - B-z8  -  - C-z8  -  - 
A-z9 359 480 B-z9 386 462 C-z9 365 478
A-z10 359 480 B-z10 386 462 C-z10 362 478
A-z11 338 474 B-z11 386 453 C-z11 359 475
A-z12 350 423 B-z12 386 465 C-z12 365 460
A-z13 NA NA B-z13 NA NA C-z13 NA NA
A-z14 NA NA B-z14 NA NA C-z14 NA NA
A-z15 374 444 B-z15 392 453 C-z15 362 454
A-z16 341 423 B-z16 383 453 C-z16 359 454
A-z17 335 423 B-z17 383 450 B-z17 362 454
D 466 538, 574 E 511 589 F 483 547
D-z1 469 538, 577 E-z1 514 580 F-z1 483 550
D-z2 469 547, 577 E-z2 511 577 F-z2 486 547
D-z3  -  - E-z3 505 580 F-z3 495 541
D-z4  -  - E-z4 505 589 F-z4 486 547
D-z5 469 535, 580 E-z5 511 586 F-z5 486 544
D-z6 466 544, 583 E-z6 511 586 F-z6 483 547
D-z7  -  - E-z7 517 589 F-z7 483 547
D-z8  -  - E-z8 520 583 F-z8 483 550
D-z9  -  - E-z9 514 577 F-z9 486 550
D-z10 469 547, 577 E-z10 511 577 F-z10 486 547
D-z11 469 547, 577 E-z11 517 580 F-z11 486 544
D-z12  -  - E-z12 514 586 F-z12 486 544
D-z13 NA NA E-z13 NA NA F-z13 NA NA
D-z14 NA NA E-z14 NA NA F-z14 NA NA
D-z15 466 538, 577 E-z15 514 574 F-z15 483 547
D-z16 469 541, 577 E-z16 514 583 F-z16 483 544







Table 4.1. Wavelengths of maximum excitation (λex) and emission (λem) for each “click” 
fluorophore. NA = not applicable. Desired MS were not found for fluorophores marked ‘NA’. 
Compounds  marked “–” had very low fluorescence intensities and were not analyzed 
 
The wavelengths of excitation and emission were largely dictated by the type of 
alkyne, but there were some variations within each alkyne series which were probably 
contributed by the different azides. Fluorescence screening of the xanthenes reveals 
another interesting feature – the alkynes used were structurally similar, but they 
differed greatly in terms of fluorescence emission. At the same concentration, 
fluorophores derived from alkynes D and E were considerably less bright than those 
from alkyne F. The reason for this is yet unclear, but it shows that minor changes in 
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the structure while preserving the same core framework can have significant effects 
on fluorophore properties. From the library, several fluorophores were selected and 
their fluorescence spectra are shown below.  
 











































































































































Figure 4.6. Emission spectra in different solvents of selected fluorophores from microplate-
based fluorescence screening 
 
To quantify the fluorescence change after triazole formation, fluorescence 
values from each “click” product were expressed as a ratio of the fluorescence value 
of control (iii) which represents the fluorescence of the corresponding alkyne in each 
alkyne series. The final output values (ranging from -50 to 50) used for computing the 
values for the heat map were generated by this formula:  



















Figure 4.7. Heat map showing fluorescence intensities of each ‘click’ product relative to its 
corresponding alkyne building block. Control (i) = alkyne + CuSO4, control (ii) = alkyne + 
sodium ascorbate, control (iii) = alkyne only. ‘Hit’ fluorophores selected for scale-up and 
purification are highlighted in black boxes. 
 
 
Red bars indicate a fluorescence increase and Blue bars indicate a fluorescence 
decrease after the “click” reaction, compared to the corresponding alkyne (white) The 
results are summarized in the form of a heat map displaying the fluorescence 
intensities of each fluorophore relative to its alkyne precursor (that is, the xanthone or 
xanthene core prior to click chemistry) (Figure 4.5).  










































Several observations can be made from the heat map. As anticipated, the 
majority of the “click” products registered an increase in fluorescence intensity (red 
squares) over the parent alkyne, but a considerable number also led to a fluorescence 
decrease (blue squares). In particular, a morpholino substituent in the azide (z4, 
column 4) led to a consistent diminution of fluorescence throughout the alkyne series, 
possibly due to photoinduced-electron-transfer (PET) quenching from the nitrogen 
atom, and a strongly electron-withdrawing nitro substituent (z8, column 8) also 
effectively quenched the fluorescence in alkynes series A-D. Notably, the “click” 
reaction between aliphatic azides (column 15-17) and the xanthene-alkynes was 
fluorogenic, implying that triazole formation is itself sufficient for fluorescence 
activation. This feature is particularly important when searching for green light-
emitting “click” fluorophores for use in labeling azide-modified biomolecules for 
bioimaging purposes.  
 
To examine in detail the fluorescence properties of our “click” fluorophores, 
we picked a few “hits” from each of the 6 alkyne series for scale-up, purification and 
characterizations. These “hits” were selected on the basis of the following points: (i) 
they showed significantly higher fluorescence intensity than their alkyne precursors; 
(ii) the “hits” give a good representation of aromatic and aliphatic azides of different 
properties; (iii) their fluorescence intensities showed some solvent sensitivity (F-z12 
and F-z17). The spectroscopic properties of 4 of the brightest “hits” and their 



































Figure 4.8. Structures of the fluorophores used for quantitative fluorescence analysis. 
 
B 366 13,500 461 0.57 7,700
B-z15 381 21,900 445 0.94 20,600
C 362 12,500 482 0.43 5,380
C-z17 358 24,200 456 0.62 15,000
F 476 11,700 537 0.11 1,290
F-z12 480 32,800 540 0.34 11,200
F-z17 479 27,700 537 0.4 11,100
Brightness 






Table 4.2. Summary of spectroscopic properties of “hit” fluorophores and alkynes 
 
It was found that triazole formation led to an increase in both molar 
absorptivity and quantum yield, leading to an overall increase in brightness (ε × Φf) of 
2-3-fold for B-z15 and C-z17 in DMSO, and ~10-fold for F-z12 in DCE and F-z17 in 
EtOH (Table 4.2).  F-z12 and F-z17 also displayed different solvent sensitivity 
despite being derivatives of the same alkyne, with F-z12 fluorescing most brightly in 
DCE, while in other solvents it is considerably less bright. F-z17 is the brightest in 
EtOH and has varying intensities in other solvents (Figure 4.8). There is however, no 
direct trend between the fluorescence intensities and solvent dielectric constants, 
suggesting that the observed solvent effects are specific to the molecular structure of 
the fluorophore. Because these effects shown in both our microplate screening and 
detailed analysis are not easily predicted, the combinatorial approach to various 
analogs is an advantage in searching for the desired fluorophore properties as 



























































































































































































































































Figure 4.9. a) Excitation and emission spectra of ‘hit’ fluorophores and their corresponding 
alkynes. b) Emission spectra of F-z12 (in DCE, green line) and F-z17 (in EtOH, red line) 
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compared against the alkyne precursor F (in each corresponding solvent; black line). Black 
arrows indicate the increase in fluorescence after the “click” reaction. c) Emission spectra of 





In conclusion, we have successfully designed and synthesized 2 new classes of 
“click” fluorophores based on the xanthone and xanthene scaffolds. The rapid 
assembly of these fluorophores enabled by “click” chemistry gives easy access to 
xanthene analogs, which are traditionally difficult to synthesize. We have also 
identified two fluorophores, F-z12 and F-z17, in which triazole-formation resulted in 
a significant fluorescence increase. While these fluorophores can potentially be used 
as green light-emitting substitutes for the existing “click” fluorophores in 
bioconjugation and bioimaging applications, further optimization of the azide moiety 













CHAPTER 5 EXPERIMENTAL SECTION 
 
5.1 General Information 
 
All chemicals were purchased from commercial vendors and used without further 
purification. Tetrahydrofuran (THF) was distilled over sodium benzophenone and 
used immediately. DMF for Sonogashira coupling was dried over CaH2 and distilled 
under reduced pressure. HPLC grade solvents are used for all other solvents. All 
reactions requiring anhydrous conditions were carried out under an argon or nitrogen 
atmosphere using oven-dried glassware. Reaction progress was monitored by TLC on 
precoated silica plates (Merck 60 F254, 0.25 µm) and spots were visualized by UV, 
basic KMnO4 or iodine. Flash column chromatography was carried out using Merck 
60 F254 0.040-0.063 µm silica gel. 1H and 13C NMR spectra were recorded on Bruker 
Avance ACF300 spectrometer. Chemical shifts are reported in parts per million 
relative to internal standard tetramethylsilane (Si(CH3)4 = 0.00 ppm) or residual 
solvent peaks (CHCl3 = 7.26 ppm, MeOH = 3.31 ppm, DMSO = 2.50 ppm). 13C-
NMR spectra are reported parts per million relative to solvent signal (CHCl3 = 77.0 
ppm, MeOH = 49.0 ppm, DMSO = 39.5 ppm). Analytical LC profiles and mass 
spectra were recorded on a Shimadzu LC-ESI-MS system or a Shimadzu LC-IT-TOF-
MS system. Reverse-phase Phenomenex Luna 5µm C18(2) 100 Å 50 X 3.0 mm 
column or Phenomenex Luna 5µm C18(2) 100 Å 150 X 3.0 mm (for peptides). 0.1% 
formic acid/H2O and 0.1% formic acid/acetonitrile were used as eluents for the LC-
ESI-MS system and 0.1% TFA/H2O and 0.1% TFA/acetonitrile for the LC-IT-TOF-
MS. The flow rate for both was 0.6 ml/min. 
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5.2 Solution-phase Synthesis of Fluorophores, Linkers and Azides 
 







To a solution of 2i (1.14 g, 5 mmol) in dry DMF (50 ml) was added imidazole 
followed by TBS-Cl (2.26 g, 15 mmol). The reaction was stirred at room temperature 
for 5 h. The reaction mixture was concentrated in vacuo to half the volume and then 
poured into H2O (100 ml) and the white precipitate formed was taken into EA (80 ml). 
The aqueous layer was further washed with EA (80 ml) and the combined organic 
phase was washed with H2O (2 × 100 ml), brine, dried over Na2SO4 and concentrated 
in vacuo. The crude product was purified by silica gel chromatography (20-50% 
EA/hexane) to afford the pure product as a white solid (1.35 g, 79%). 1H-NMR (500 
MHz, CDCl3) δ 8.17 (d, J = 8.9 Hz, 1H), 8.11 (d, J = 8.2 Hz), 6.81 (dd, J = 8.2, 1.9 
Hz, 1H), 6.80 (apparent s, 1H), 6.63 (dd, J = 8.8, 2.5 Hz, 1H), 6.55 (d, J = 1.9 Hz, 1H), 








To a solution of 2ii (1.35 g, 3.96 mmol) and pyridine (1.92 ml, 23.7 mmol) in DMF 
(30 ml) was added CPh3Cl (3.32 g, 11.9 mmol) portionwise at room temperature and 
stirred for 4 h. The reaction was diluted with H2O (100 ml) and the white precipitate 
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formed was taken into EA (70 ml). The aqueous layer was extracted with EA (70 ml) 
and the combined organic phase was washed with H2O (2 × 100 ml), brine, dried over 
Na2SO4 and concentrated in vacuo. The crude product was purified by silica gel 
chromatography (10-25% EA/hexane) to afford the pure product as a white solid 
(1.92 g, 83%). 1H-NMR (500 MHz, CDCl3) δ 8.10 (d, J = 8.9 Hz, 1H), 7.93 (d, J = 
8.9 Hz, 1H), 7.36 – 7.25 (m, 15H), 6.76 (dd, J = 8.8, 1.9 Hz, 1H), 6.67 (d, J = 2.5 Hz, 
1H), 6.53 (dd, J = 8.9, 2.5 Hz, 1H), 0.98 (s, 9H), 0.24 9s, 6H). ESI-MS: m/z [M+1]+ 





To a solution of o-tolylmagnesium bromide (2.0 M in Et2O, 2.5 ml, 5.0 mmol) in 
freshly distilled THF (40 ml) was added dropwise 2iii (0.58 g, 1.0 mmol) dissolved in 
THF (20 ml) and heated at 60°C under N2 atmosphere for 16 hrs. Another portion of 
the Grignard reagent (2 eq) was added dropwise and the reaction was stirred for 
another 16 hrs. The reaction was then quenched with the addition of H2O (THF/H2O, 
1:1). The mixture was neutralized to pH 6 with the slow addition of 1N HCl at 0°C, 
followed by extraction with ether twice, then EtOAc. The combined organic layers 
were washed with H2O, brine, dried over Na2SO4 and concentrated in vacuo. The 
crude compound was purified by silica gel chromatography (100% DCM – 10% 
MeOH/DCM) to give a red solid (0.20 g, 36%). 1H-NMR (300 MHz, DMSO-d6) δ 
8.33 (s, 1H), 7.46 – 7.16 (m, 19H), 6.70 (br s, 1H), 6.69 (d, J = 9.5 Hz, 1H), 6.57 
(apparent d, J = 9.0 Hz, 1H), 6.28 (dd, J = 9.7, 1.5 Hz, 1H), 6.04 (d, J = 1.5 Hz, 1H). 





3-acetamidophenol was synthesized from 3-aminophenol according to a modified 
published procedure. To a rapidly stirred suspension of ZnO (16.3 g, 0.2 mol), acetic 
anhydride (56.7 ml, 0.6 mol) and DCM (400 ml) in a 1-litre conical flask was added 
3-aminophenol (43.6 g, 0.4 mol) portionwise over 5 min. (Caution: Heat from the 
reaction causes the DCM to boil, but it is not necessary to cool the reaction mixture). 
After stirring for 10 min by which time the boiling of the DCM would have subsided, 
the suspension was filtered and washed rapidly with DCM (100 ml). The solid was 
collected and washed with EA repeatedly until all the product is extracted into EA. 
EA was then removed in vacuo and the crude product recrystallized in hot EA to give 
pinkish white crystals as the pure product. A second crop of crystals may be obtained 
by recrystallization in EA/hexane. Yield = 80% (48.3 g). 1H-NMR values were in 







Compounds 2-1 and 2-2 were synthesized according to published procedures1 with 
some modifications. To a solution of 3-acetamidophenol (18.1 g, 120 mmol) in DMF 
was added K2CO3 (16.6 g, 120 mmol) and with vigorous stirring. 2-chloro-4-
nitrobenzoic acid (12.1 g, 60 mmol) and Cu powder (0.4 g, 6 mmol) was then added 
and the reaction was heated to 130°C for 16 hrs. The reaction was cooled to room 
temperature and poured into 5N HCl (50 ml) and ice (total volume of 500 ml). The 
pH was adjusted to 1 by the further addition of 5N HCl if necessary. The mixture was 
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stirred at 0°C until a pale brown solid is formed. The solid was then filtered, washed 
with cold H2O and air-dried. This solid was added portionwise to conc. H2SO4 (100 
ml) and heated at 80°C for 1 hr. After cooling to room temperature, the reaction 
mixture was poured slowly onto ice and stirred until a reddish-brown solid is formed. 
This solid was filtered and stirred in 20% w/v Na2CO3 solution (200 ml) until the gas 
evolution ceased. The crude product was then filtered and washed with cold H2O. The 
product was then suspended in hot acetonitrile (250 ml) and stirred until a shiny 
yellowish-brown solid was observed. The suspension was then removed from the heat 
and filtered while hot. The product thus obtained was washed with cold acetonitrile 
and dried. The combined washings were concentrated in vacuo and the crude product 
was suspended in acetonitrile or acetone and sonicated. The red solid that settled to 
the bottom of the flask was removed by decanting. Repeating this process removed 
most of the side product (red solid). The remaining solid suspended in the solution 
was then recrystallized in acetone or acetonitrile to give a yellow solid (3.07 g, 20% 
over 2 steps). Note: the 3-acetamidophenol obtained from Sigma-Aldrich typically 
gave lower yields and product was tainted with a brown substance that was not easily 
removed.  1H-NMR (300 MHz, DMSO) δ 8.37 (d, J = 2.1 Hz, 1H), 8.32 (d, J = 8.7 
Hz, 1H), 8.15 (dd, J = 8.7, 2.13 Hz, 1H), 7.88 (d, J = 8.7 Hz, 1H), 6.74 (br s, 2H), 
6.72 (dd, J = 8.7, 2.0 Hz, 1H), 6.56 (d, J = 2.0 Hz, 1H). ESI-MS: m/z [M-1]- calcd: 








To a solution of 2-1 (3.0 g, 11.7 mmol) in conc. H2SO4 (30 ml) and water (15 ml) at 
0°C was added dropwise a solution of NaNO2 (2.43 g, 35.1 mmol) in H2O (10 ml). 
The reaction was stirred at 0°C for 1hr, then poured into boiling H2O (100 ml). The 
mixture was stirred at 90°C until an orange-brown solid was formed. The suspension 
was then cooled to room temperature and filtered. The solid was washed with cold 
H2O and dried in vacuo to yield the product (2.80 g, 93%) which was pure enough for 
the next reaction. 1H-NMR (300 MHz, DMSO-d6) δ 8.22 (s, 1H), 8.21 (d, J = 8.6 Hz, 
1H), 8.06 (dd, J = 8.7, 1.8 Hz, 1H), 7.91 (d, J = 8.9 Hz, 1H), 6.84, (dd, J = 8.8, 1.89 
Hz, 1H), 6.74 (d, J = 1.8 Hz, 1H). 13C-NMR (75 MHz, DMSO-d6) δ 173.5, 164.7, 
157.7, 154.9, 150.4, 128.1, 127.8, 125.0, 118.0, 114.8, 113.8, 113.7, 102.1. ESI-MS: 
m/z [M-1]- calcd: 256.0, found 256.3. 
 
General procedure for the synthesis of 2-3a and 2-3b: 
To a solution of 2-2 (3.0 g, 11.7 mmol) in DMF at room temperature under N2 
atmosphere was added anhydrous K2CO3 (3.23 g, 23.4 mmol) and then 
dimethylsulfate (for 2-3a, 2.11 ml, 23.4 mmol) or tert-butyldimethylsilyl 5-iodopentyl 
ether 2-12 (for 2-3b, 4.99 g, 15.2 mmol; see section 5.2.3 for synthesis). The reaction 
was monitored by TLC to completion. The reaction mixture was then filtered and 
DMF was removed in vacuo. The solid residue was taken into DCM and washed with 
NaHCO3, water, brine and dried over Na2SO4. After the removal of the solvent, the 








White solid. Yield = 70%. 1H-NMR (300 MHz, CDCl3) δ 8.45 (d, J = 8.7 Hz, 1H), 
8.34 (d, J = 2.1 Hz, 1H), 8.25 (d, J = 9.0 Hz, 1H), 8.16 (dd, J = 8.7, 2.1 Hz, 1H), 7.01 
(dd, J = 8.9, 2.3 Hz, 1H), 6.93 (d, J = 2.3 Hz, 1H). 13C-NMR (75 MHz, CDCl3) δ 








White solid. Yield = 82%. 1H-NMR (300 MHz, CDCl3) δ 8.40 (d, J = 8.7 Hz, 1H), 
8.23 (d, J = 2.1 Hz, 1H), 8.16 (d, J = 8.9 Hz, 1H), 8.09 (dd, J = 8.7, 2.1 Hz, 1H), 6.93 
(dd, J = 8.7, 2.3 Hz, 1H), 6.83 (d, J = 2.1 Hz, 1H), 4.08 (t, J = 6.4 Hz, 2H), 3.65 (t, J 
= 5.9 Hz, 2H), 1.91 – 1.83 (m, 2H), 1.66 – 1.53 (m, 4H), 0.89 (s, 9H), 0.05 (s, 6H). 
13C-NMR (75 MHz, CDCl3) δ 174.5, 165.3, 158.2, 155.5, 150.8, 128.4, 128.3, 125.7, 
117.9, 115.3, 114.6, 113.8, 100.7, 68.9, 62.8, 32.4, 28.7, 25.9, 22.3, 18.3, -5.3. ESI-







To a suspension of 2-3a (1.2 g, 4.42 mmol) in EtOH (30 ml) was added SnCl2.2H2O 
(2.89 g, 12.8 mmol), then refluxed overnight. The reaction was cooled to room 
temperature and EtOH removed in vacuo. Saturated NaHCO3 (30 ml) was then added 
to the solid, stirred for 5 min and filtered. Acetone was added to dissolve the product. 
The remaining tin salts were removed by filtration, and washed with acetone. The 
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pure product (1.07 g, 90%) was obtained after removal of acetone in vacuo.  1H-NMR 
(500 MHz, DMSO) δ 7.99 (d, J = 8.9 Hz, 1H), 7.82 (d, J = 8.9 Hz, 1H), 7.01 (d, J = 
1.9 Hz, 1H), 6.94 (dd, J = 8.8, 2.5 Hz, 1H), 6.65 (dd, J = 8.5, 1.9 Hz, 1H), 6.42 (s, 
2H), 3.88 (s, 3H). 13C-NMR (125 MHz, DMSO) δ 173.3, 163.9, 158.0, 157.2, 155.3, 
127.3, 127.2, 115.2, 112.5, 112.2, 110.7, 100.4, 97.6, 55.9. ESI-MS: m/z [M-1]- calcd: 







To a solution of 2-3b (4.5 g, 9.46 mmol) in EtOAc (60 ml) was added 10% Pd/C 
(0.45 g) and stirred under hydrogen atmosphere at room temperature overnight. After 
the completion of the reaction, the mixture was filtered through celite and 
concentrated to give the pure product (3.72 g, 92%) as a yellow solid.  1H-NMR (300 
MHz, CDCl3) δ 8.18 (d, J = 8.8 Hz, 1H), 8.09 (d, J = 8.5 Hz), 6.86 (dd, J = 8.8, 2.3 
Hz, 1H), 6.78 (d, J = 2.3 Hz, 1H), 6.62 (dd, J = 8.5, 2.0 Hz, 1H), 6.54 (d, J = 2.0 Hz, 
1H), 4.05 (t, J = 6.4 Hz, 2H), 3.70 – 3.63 (m, 2H), 1.87 – 1.80 (m, 2H), 1.62 – 1.53 
(m, 4H), 0.90 (s, 9H), -0.01 (s, 6H). 13C-NMR (75 MHz, CDCl3) δ 175.3, 163.9, 158.3, 
157.8, 152.4, 128.4, 128.0, 115.8, 113.8, 112.9, 112.3, 100.64, 99.9, 68.5, 62.9, 32.4, 
28.8, 26.0, 22.3, 18.3, -5.3. ESI-MS: m/z [M+1]+ calcd: 428.2, found 428.2. 
 
General procedure for the synthesis of 2-5a and 2-5b: 
To a solution of 2-4a or 2-4b in DCM at room temperature was added triethylamine 
followed by trityl chloride portionwise. The reaction was stirred for 1 hr at room 
temperature, then H2O was added. The two layers were separated and the aqueous 
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layer extracted with DCM. The combined DCM layers were washed with water, brine 
and dried over Na2SO4. After the removal of the solvent in vacuo, the crude product 







Yield = 88%. 1H-NMR (300 MHz, CDCl3) δ 8.14 (d, J = 8.9 Hz, 1H), 7.93 (d, J = 8.7 
Hz, 1H), 7.37-7.26 (m, 15H), 6.83 (apparent d, J = 8.9 Hz, 1H), 6.69 (d, J = 2.3 Hz, 
1H), 6.08 (d, J = 2.1 Hz, 1H), 5.67 (s, 1H), 3.85 (s, 3H). 13C-NMR (75 MHz, CDCl3) 
δ 175.2, 164.2, 157.8, 157.5, 151.8, 144.3, 129.1, 128.2, 127.9, 127.3, 126.9, 116.0, 








Yield = 97%. 1H-NMR (300 MHz, CDCl3) δ 8.12 (d, J = 8.9 Hz, 1H), 7.93 (d, J = 8.7 
Hz, 1H), 7.37 – 7.25 (m, 15H), 6.82 (dd, J = 8.9, 2.3 Hz, 1H), 6.67 (d, J = 2.2 Hz, 
1H), 6.53 (apparent d, J = 8.8, 1H), 6.08 (d, J = 2.3 Hz, 1H), 4.00 (t, J = 6.5 Hz, 2H), 
3.63 (t, J = 6.1 Hz, 2H), 1.87 – 1.77 (m, 2H), 1.59 – 1.50 (m, 4H), 0.89 (s, 9H), 0.05 
(s, 6H). 13C-NMR (75 MHz, CDCl3) δ 175.2, 163.7, 157.8, 157.5, 144.3, 129.0, 128.2, 
127.8, 127.3, 126.9, 115.7, 113.8, 113.0, 112.8, 101.3, 100.5, 71.8, 68.4, 62.9, 32.4, 




General procedure for the synthesis of SG1 and SG2: 
To a solution of o-tolylmagnesium bromide (2.0 M in Et2O, 5 eq) in freshly distilled 
THF (0.5 M) was added dropwise 2-5a or 2-5b dissolved in THF (0.1 M) and heated 
at 60°C under N2 atmosphere for 16 hrs. Another portion of the Grignard reagent (2 
eq) was added dropwise and the reaction was stirred for another 16 hrs. The reaction 
was then quenched with the addition of H2O (THF/H2O, 1:1). The mixture was 
neutralized to pH 6 with the slow addition of 1N HCl at 0°C, followed by extraction 
with ether twice, then EtOAc. The combined organic layers were washed with H2O, 
brine, dried over Na2SO4 and concentrated in vacuo. The crude compound was 
purified by silica gel chromatography (100% DCM – 10% MeOH/DCM). This 
product was then dissolved in DCM and H2O followed by addition of trifluoroacetic 
acid (DCM:TFA:H2O, 7:2:1) at room temperature. The reaction was stirred for 30 min, 
then H2O was added to the reaction and the two layers were separated. The DCM 
layer was washed with sat. NaHCO3, water, brine and dried over Na2SO4. After the 
removal of the solvent, the crude product was purified on a short silica gel column. 





Bright red solid. Yield = 68% from 2-5a. 1H-NMR (500 MHz, MeOD) δ 7.89 (s, 1H), 
7.59 (t, J = 7.55 Hz, 1H), 7.53 (d, J = 7.55 Hz, 1H), 7.48 (t, J = 7.55 Hz, 1H), 7.46 (d, 
J = 2.5 Hz, 1H), 7.35 (d, J = 8.80 Hz, 1H), 7.32 (d, J = 9.45 Hz, 1H), 7.29 (d, J = 
7.55 Hz, 1H), 7.17 (dd, J = 8.85, 2.5, 1.9 Hz, 1H), 7.06 (dd, J = 9.45, 1.85 Hz, 1H), 
6.98 (d, J = 2.55 Hz, 1H), 4.08 (s, 3H), 2.06 (s, 3H). 13C-NMR (125 MHz, MeOD) δ 
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169.7, 164.3, 161.7, 161.5, 158.5, 137.2, 134.4, 132.8, 132.3, 132.0, 131.6, 130.1, 
127.4, 121.3, 118.3, 118.3 116.7, 101.6, 98.6, 57.5, 19.7. IT-TOF-MS: m/z [M+1]+ 





Red solid. Yield = 56% from 2-5b. 1H-NMR (500 MHz, MeOD) δ 7.89 (s, 1H), 7.59 
(dt, J = 7.55, 1.25 Hz, 1H), 7.53 (d, J = 7.55 Hz, 1H), 7.48 (t, J = 7.58 Hz, 1H), 7.43 
(d, J = 2.5 Hz, 1H), 7.33 (d, J = 9.45 Hz, 1H), 7.31 (d, J = 9.45 Hz, 1H), 7.28 (d, J = 
7.55 Hz, 1H), 7.15 (dd, J = 8.85, 2.50 Hz, 1H), 7.05 (dd, J = 9.45, 1.90 Hz, 1H), 6.97 
(d, J = 1.90 Hz, 1H), 4.29 (t, J = 6.60 Hz, 2H), 3.60 (t, J = 6.30 Hz, 2H), 2.05 (s, 3H), 
1.94 – 1.89 (m, 2H), 1.65 – 1.57 (m, 4H). 13C-NMR (125 MHz, MeOD) δ 169.1, 
164.2, 161.7, 161.5, 158.5, 137.2, 134.3, 132.8, 132.3, 132.0, 131.6, 130.1, 127.4, 
121.3, 118.6, 118.2, 116.6, 102.0, 98.6, 71.1, 62.7, 33.2, 29.7, 23.4, 19.7. IT-TOF-MS: 









To a solution of Fmoc-Asp(OtBu)-OH (323 mg, 0.78 mmol), HBTU (297 mg, 0.784 
mmol) and HOBt (106 mg, 0.784 mmol) in DMF (10 ml) was added DIEA (0.315 ml, 
1.81 mmol) and stirred for 5 min at room temperature under nitrogen atmosphere. 2-
6a (190 mg, 0.603 mmol) was then added and the reaction stirred for 1 hr. The 
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reaction was quenched by pouring the mixture into water. After extracting 3 times 
with EA, the combined EA layers were washed with water, brine, dried over Na2SO4 
and concentrated. The crude product was purified by silica gel chromatography to 
give a yellowish white solid. This solid was then dissolved in DCM and 
trifluoroacetic acid was added. The reaction was stirred for 5 hrs at room temperature, 
after which the solvent and TFA was removed in vacuo. The residue was taken into 
DCM and washed twice with water, brine and dried over Na2SO4. Evaporation of the 
solvent gave 2-7 (0.267 g, 68% over 2 steps) which was sufficiently pure (as shown 
by HPLC analysis) to be used for peptide synthesis. IT-TOF-MS: m/z [M+1]+ calcd 





To a mixture of 2-6b (1.00 g, 2.58 mmol) and NaHCO3 (0.87 g, 10.3 mmol) in 1:1 
THF/H2O (40 ml) at 0°C was added Fmoc-Cl. The temperature was gradually raised 
to room temperature and stirred for 4 hrs. H2O was added and the aqueous layer 
extracted with ether (3X). The combined ether layers were washed with brine, dried 
over Na2SO4, filtered and concentrated. The pure product was obtained as an orange-
red foam solid (1.02 g, 65%) after column purification (100% DCM – 5% 







To a solution of 2-8 (1.00 g, 1.64 mmol) in DCM (15 ml) was added Dess-Martin 
periodinane (1.25 g, 2.95 mmol) at 0°C. After 15 min, the ice bath was removed and 
stirring was continued at room temperature for 2 hrs. Saturated NaHCO3 was added to 
the reaction and stirred until the two layers became clear. The DCM layer was then 
separated, washed with H2O, brine, dried over Na2SO4, filtered and concentrated. The 
product was purified on a short silica gel column to afford an orange-red foam solid 







Fmoc-SG2-ol (2-8) (1.83 g, 3 mmol) was dissolved in DMF (25 ml) and cooled to 
0οC under a nitrogen atmosphere. PDC (4.51 g, 12 mmol) was added portionwise over 
5 min to the rapidly stirred solution. The temperature was slowly raised to room 
temperature and stirred for 16 h. The reaction mixture was poured into an ice/water 
mixture (100 ml) and stirred for 15 min. The orange precipitate formed was filtered 
and washed with cold water (5 ×). The resulting solid was dried briefly in vacuo, and 
then lyophilized to remove the remaining traces of water (1.59 g, 85%). This solid 







Fmoc-SG2-COOH (0.94 g, 1.5 mmol) was dissolved in freshly distilled DCM (20 ml) 
under a nitrogen atmosphere and cooled to 0οC. A catalytic amount of DMF was 
added and then oxalyl chloride (0.26 ml, 3 mmol) was added dropwise over 3 min. 
The reaction was then slowly raised to RT and stirred for another 3 h. The solvent and 
oxalyl chloride was removed in vacuo to afford a yellow solid (0.89 g, 92%) which 
was used without further purification.  
 
5.2.2 Synthesis of Alkynes A – F 
 
General procedure for the conversion of phenols to triflates 
To a suspension of the phenol (1 mmol) in dry DCM (15 ml) was added dry pyridine 
(0.40 ml, 5 mmol) and cooled to 0°C. Trifluoromethanesulfonic anhydride (0.25 ml, 
1.5 mmol) was then added dropwise at 0°C. The reaction was gradually raised to 
room temperature and stirred for another 2 hrs. H2O (10 ml) was then added to quench 
the reaction. After stirring for 5 min, the two phases were separated and the aqueous 
layer extracted with DCM (15 ml). The combined organic phase was washed with 1N 
HCl (2 × 10 ml), water (10 ml), dried over Na2SO4 and concentrated in vacuo. The 
pure product was isolated by silica gel chromatography using EtOAc/hexane as the 
eluent. 
 
General procedure for Sonogashira coupling 
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Dry DMF was degassed by bubbling argon gas for 30-45 min. The triflate (1 mmol), 
PdCl2(PPh3)2 (70.2 mg, 0.1 mmol) and CuI (38.1 mg, 0.2 mmol) were dissolved in 
degassed DMF (15 ml) under an argon atmosphere Triethylamine (1.39 ml, 10 mmol) 
was then added followed by ethynyltrimethylsilane (0.28 ml, 2 mmol). The reaction 
was stirred for 2 hrs and poured into water (40 ml) and extracted with ethyl acetate (3 
× 20 ml). The combined organic phase was washed with brine, dried over Na2SO4 and 
concentrated. The crude product was purified by silica gel chromatography using 
EtOAc/hexane as the eluent. 
 
General procedure for the deprotection of the trimethylsilyl (TMS) group for alkynes 
A-C 
The TMS-protected alkynes (1 mmol) were dissolved in MeOH/THF 1:2 (30 ml) and 
1 N NaOH (10 ml) was added at room temperature. The reaction was stirred for 30 
min. Ether was added to the reaction mixture and stirred for 15 min, then the two 
phases were separated. The aqueous phase was extracted with diethyl ether or EtOAc 
(2 × 20 ml). The combined organic phase was washed with brine, dried over Na2SO4 
and concentrated in vacuo. The pure product was obtained by purification over a short 







To a solution of 3,6-dihydroxy-xanthen-9-one (1.14 g, 5 mmol) in DMF (80 ml) was 
added anhydrous powdered K2CO3 (0.90 g, 6.5 mmol) and stirred for 2 hrs at room 
temperature until the K2CO3 dissolved completely. Dimethylsulfate (0.48 ml, 5 mmol) 
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in DMF (10 ml) was then added dropwise at room temperature over 20 min. The 
reaction was stirred for an additional 2 hrs. The solid formed was filtered off and then 
the DMF was removed in vacuo. H2O (30 ml) was added to the residue and extracted 
with EtOAc (4 × 50 ml). The combined organic phase was washed with water (50 ml), 
brine, dried over Na2SO4 and concentrated. The product was isolated by silica gel 
chromatography (30-50% EtOAc/hexane) to give 4-1i as an off-white solid (0.52 g, 
43%). The remaining starting material was recovered in approximately 30% yield. 1H-
NMR (300 MHz, DMSO) δ 8.04 (d, J = 8.9 Hz, 1H), 8.00 (d, J = 8.7 Hz, 1H), 7.09 (d, 
J = 2.3 Hz, 1H), 7.00 (dd, J = 8.9, 2.5 Hz, 1H), 6.89 (dd, J = 8.7, 2.3 Hz), 6.84 (d, J 






6-methoxy-9-oxo-9H-xanthen-3-yl trifluoromethanesulfonate (4-2a) 
4-2a was obtained from 4-1i as a white solid following the general procedure for the 
conversion of phenols to triflates. Yield = 84%. 1H-NMR (300 MHz, CDCl3) δ 8.42 
(d, J = 8.9 Hz, 1H), 8.24 (d, J = 8.9 Hz, 1H), 7.42 (d, J = 2.3 Hz, 1H), 7.27 (dd, J = 
8.9, 2.3 Hz, 1H), 6.98 (dd, J = 8.9, 2.3 Hz, 1H), 6.89 (d, J = 2.5 Hz, 1H), 3.95 (s, 3H). 
13C-NMR (75 MHz, CDCl3) δ 174.8, 165.5, 158.1, 156.5, 152.6, 129.3, 128.4, 121.8, 










4-3a was obtained from 4-2a as a white solid following the general procedure for 
Sonogashira coupling. Yield = 60%. 1H-NMR (300 MHz, CDCl3) δ 8.24 (d, J = 8.1 
Hz, 1H), 8.23 (d, J = 8.9 Hz, 1H), 7.53 (d, J = 1.3 Hz, 1H), 7.41 (dd, J = 8.2, 1.5 Hz, 
1H), 6.94 (dd, J = 8.9, 2.3 Hz, 1H), 6.87 (d, J = 2.3 Hz, 1H), 3.94 (s, 3H), 0.29 (s, 
9H). 13C-NMR (75 MHz, CDCl3) δ 175.6, 165.2, 158.1, 155.8, 129.1, 128.3, 127.3, 
126.6, 121.6, 121.6, 120.9, 115.9, 113.4, 103.4, 100.3, 98.9, 55.8, -0.22. ESI-MS: m/z 







Alkyne A was obtained from 4-3a as a white solid following the general procedure 
for the deprotection of TMS-protected alkynes A-C. Yield = 90%. 1H-NMR (300 
MHz, CDCl3) δ 8.26 (d, J = 8.9 Hz, 1H), 8.24 (d, J = 9.7 Hz, 1H), 7.57 (d, J = 1.3 Hz, 
1H), 7.44 (d, J = 8.2, 1.3 Hz, 1H), 6.95 (dd, J = 8.9, 2.5 Hz, 1H), 6.88 (d, J = 2.3 Hz, 
1H), 3.94 (s, 3H), 3.31 (s, 1H). 13C-NMR (75 MHz, CDCl3) δ 175.6, 165.3, 158.1, 
155.7, 128.3, 128.0, 127.4, 126.7, 121.3, 115.8, 113.6, 100.2, 82.3, 80.9, 55.9. ESI-





A solution of 4-3a (0.129 g, 0.4 mmol) in dry THF (10 ml) was added to o-
tolylmagnesium bromide (2.0 M in Et2O, 1.0 ml, 2 mmol) in dry THF (10 ml) under 
an argon atmosphere at room temperature. The reaction was then heated to 50°C and 
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stirred for 5 hrs, and quenched by the dropwise addition of H2O until gas evolution 
ceased. The reaction was then neutralized with 2 N HCl and diluted with the addition 
of diethyl ether (20 ml) and stirred for 5 min. The 2 phases were separated and the 
aqueous phase extracted with Et2O (2 ×10 ml). The combined organic phase was 
washed with H2O (10 ml), brine, dried over Na2SO4 and concentrated to give the 
intermediate tertiary alcohol which was used immediately without further purification. 
The alcohol was dissolved in dry DCM (20 ml) and cooled to -78° in a dry ice-
acetone bath. BBr3 (0.15 ml, 1.6 mmol) was added dropwise to the solution. The 
reaction was gradually raised to room temperature and stirred for 16 hrs. The reaction 
was poured slowly into ice-water (~ 10 ml) with vigorous stirring and stirred for 
another 15 min. The 2 phases were separated and the aqueous phase was extracted 
with DCM (2 × 10 ml). The combined organic phase was washed with brine, dried 
over Na2SO4 and concentrated. The pure product D was obtained by silica gel 
chromatography (20-50% EtOAc/hexane) as a bright orange solid (27.3 mg, 22% over 
2 steps). 1H-NMR (300 MHz, DMSO) δ 7.69 (d, J = 1.5 Hz, 1H), 7.53 – 7.36 (m, 5H), 
6.95 (d, J = 8.2 Hz, 1H), 6.89 (d, J = 9.7 Hz, 1H), 6.59 (dd, J = 9.8, 2.0 Hz, 1H), 6.26 
(d, J = 2.0 Hz, 1H), 4.60 (s, 1H), 2.03 (s, 3H). 13C-NMR (75 MHz, DMSO-d6) δ 
184.4, 157.8, 151.5, 147.1, 135.7, 131.6, 130.8, 130.5, 129.6, 129.1, 128.0, 127.9, 
126.4, 126.2, 120.6, 120.5, 119.5, 105.1, 85.1, 82.3. (Note: 1 C was not resolved). 







Compound 4-1ii was synthesized following a literature procedure3. 
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1H-NMR (300 MHz, CDCl3) 8.45 (d, J = 8.9 Hz, 2H), 7.49 (d, J = 2.3 Hz, 2H), 7.36 






6-(diethylamino)-9-oxo-9H-xanthen-3-yl trifluoromethanesulfonate (4-2b) 
4-2b was synthesized from 4-1ii following a reported procedure3 with modifications. 
Diethylamine (1.06 ml, 20 mmol) was added to a solution of 4-1ii (0.985 g, 2 mmol) 
in DMSO (15 ml) at room temperature. The reaction was stirred at 80°C for 4 hrs, 
followed by removal of diethylamine in vacuo. The solution was then poured into ice-
water (15 ml) and the solid residue was taken up into diethyl ether. The aqueous layer 
was extracted with diethyl ether (2 × 15 ml). The combined organic phase was 
washed twice with H2O, brine, dried over Na2SO4 and concentrated. The pure product 
was isolated by silica gel chromatography (20-30% EtOAc/hexane) as a yellow solid 
(0.357 g, 43%). 1H-NMR (300 MHz, CDCl3) δ 8.37 (d, J = 8.9 Hz, 1H), 8.10 (d, J = 
9.2 Hz, 1H), 7.33 (d, J = 2.3 Hz, 1H), 7.22 (dd, J = 8.9, 2.3 Hz, 1H), 6.72 (dd, J = 9.0, 
2.5 Hz, 1H), 6.47 (d, J = 2.3 Hz), 3.48 (q, J = 7.1 Hz, 4H), 1.29 (t, J = 7.1 Hz, 6 H). 
13C-NMR (75 MHz, CDCl3) δ 173.9, 158.8, 156.4, 153.2, 152.1, 129.0, 128.3, 122.2, 
116.4, 110.9, 110.6, 110.0, 96.1, 44.9, 12.4. 19F-NMR (282 MHz, CDCl3) δ 3.3 (s) 









4-3b was obtained from 4-3a as a yellow solid following the general procedure for 
Sonogashira coupling. Yield = 81%. 1H-NMR (300 MHz, CDCl3) δ 8.21 (d, J = 8.0 
Hz, 1H), 8.11 (d, J = 9.2 Hz, 1H), 7.46 (d, J = 1.5 Hz, 1H), 7.37 (dd, J = 8.1, 1.5 Hz, 
1H), 6.69 (d, J = 9.0, 2.5 Hz, 1H), 6.45 (d, J = 2.5 Hz, 1H), 3.47 (q, J = 7.1 Hz, 4H), 
1.25 (t, J = 7.1 Hz, 6H), 0.28 (s, 9H). 13C-NMR (75 MHz, CDCl3) δ 174.9, 158.7, 
155.6, 152.9, 128.2, 128.1, 126.8, 126.4, 122.1, 120.6, 111.3, 109.6, 103.8, 98.0, 96.2, 







Alkyne B was obtained from 4-3b as a yellow solid following the general procedure 
for deprotection of TMS-protected alkynes A-C. Yield = 92%. 1H-NMR (300 MHz, 
CDCl3) δ 8.23 (d, J = 8.0 Hz, 1H), 8.12 (d, J = 9.2 Hz, 1H), 7.50 (d, J = 1.1 Hz, 1H), 
7.40 (dd, J = 8.0, 1.5 Hz, 1H), 6.70 (dd, J = 9.2, 2.5 Hz, 1H), 6.47 (d, J = 2.5 Hz, 1H), 
3.48 (q, J = 7.1 Hz, 4H), 3.27 (s, 1H), 1.26 (t, J = 7.1 Hz, 6H). 13C-NMR (75 MHz, 
CDCl3) δ 174.8, 158.7, 155.6, 153.0, 128.2, 127.1, 126.9, 126.6, 122.5, 121.0, 111.3, 







ylidene)ethanaminium chloride (4-3ii) 
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A solution of 4-3b (0.145 g, 0.4 mmol) in dry THF (10 ml) was added to o-
tolylmagnesium bromide (2.0 M in Et2O, 1.0 ml, 2 mmol) in dry THF (10 ml) under 
an argon atmosphere at room temperature. The reaction was then heated to 50°C and 
stirred for 12 hrs, and quenched by the dropwise addition of H2O until gas evolution 
ceased. The reaction was then acidified with 2 N HCl to pH = 1 and diluted with the 
addition of DCM (20 ml) and stirred for 5 min. The 2 phases were then separated and 
the aqueous layer saturated with brine (20 ml) and extracted with DCM (4 × 20 ml). 
The combined organic phase was dried over Na2SO4, filtered and concentrated. This 






Compound 4-3ii was stirred in a solution of 1:1 1N NaOH/MeOH (20 ml) at room 
temperature for 1 hr. The reaction was acidified to pH = 1 and MeOH was removed in 
vacuo. The solution was then saturated with brine (10 ml) and extracted with DCM (4 
× 20 ml). The combined organic phase was dried over Na2SO4, filtered and 
concentrated. The pure product E was isolated as a dark purple solid (0.112 g, 70% 
over 2 steps) by silica gel chromatography (100% DCM – 10% MeOH/DCM). 1H-
NMR (300 MHz, DMSO) δ 7.99 (d, J = 1.3 Hz, 1H), 7.64 – 7.48 (m, 5H), 7.35 – 7.21 
(m, 4H), 4.90 (s, 1H), 3.93 – 3.81 (m, 4H), 2.03 (s, 3H), 1.33 – 1.23 (m, 6H). 13C-
NMR (75 MHz, DMSO) δ 159.0, 158.5, 156.4, 153.1, 135.8, 132.5, 130.8, 130.7, 
130.3, 129.3-129.1 (5 C), 126.2, 121.1, 120.1, 119.8, 96.8, 87.7, 82.1, 46.9, 46.8, 19.2, 







6-nitro-9-oxo-9H-xanthen-3-yl trifluoromethanesulfonate (4-5) 
4-5 was obtained from 3-hydroxy-6-nitro-9H-xanthen-9-one4 4-4 as an off-white solid 
following the general procedure for the conversion of phenols to the corresponding 
triflates. Yield = 87%. 1H-NMR (300 MHz, CDCl3) δ 8.53 (d, J = 8.7 Hz, 1H), 8.47 
(d, J = 8.9 Hz, 1H), 8.41 (d, J = 2.1 Hz, 1H), 8.24 (dd, J = 8.7, 2.0 Hz, 1H), 7.55 (d, J 
= 2.3 Hz, 1H), 7.38 (dd, J = 8.7, 2.3 Hz, 1H). 13C-NMR (75 MHz, CDCl3) δ 174.6, 
156.8, 155.7, 153.6, 151.6, 129.7, 128.9, 125.3, 121.4, 120.8, 118.9, 118.4, 116.6, 








4-6 was obtained from 4-5 as a white solid following the general procedure for 
Sonogashira coupling. Yield = 65%. 1H-NMR (300 MHz, CDCl3) δ 8.49 (d, J = 8.7 
Hz, 1H), 8.37 (d, J = 2.0 Hz, 1H), 8.26 (d, J = 8.2 Hz, 1H), 8.18 (dd, J = 8.7, 2.1 Hz, 
1H), 7.63 (d, J = 1.3 Hz, 1H), 7.49 (d, J = 8.2, 1.3 Hz, 1H), 0.30 (s, 9H). 13C-NMR 
(75 MHz, CDCl3) δ 175.3, 156.0, 155.7, 151.4, 131.0, 128.7, 128.4, 126.8, 125.6, 









To a solution of 4-6 (0.169 g, 0.5 mmol) in 3:1 MeOH/THF (20 ml) was added 
saturated NH4Cl solution (2 ml) followed by Zn powder (0.327 g, 5 mmol) and stirred 
for 30 min. The solids were then removed by filtration and washed with EtOAc (30 
ml). The solution was concentrated in vacuo to approximately half the volume and 
H2O (20 ml) was added. The 2 phases were separated and the aqueous phase was 
extracted with EtOAc (2 × 10 ml). The combined organic phase was washed with 
H2O, brine, dried over Na2SO4, filtered and concentrated. This crude product was then 







Alkyne C was obtained as a yellow solid (95 mg, 81% over 2 steps) from the 
intermediate aniline 4-7 following the general procedure for the deprotection of the 
TMS group for alkynes A-C. 1H-NMR (300 MHz, DMSO) δ 8.07 (d, J = 8.2 Hz, 1H), 
7.84 (d, J = 8.7 Hz, 1H), 7.65 (d, J = 1.3 Hz, 1H), 7.44 (dd, J = 8.1, 1.3 Hz, 1H), 6.66 
(dd, J = 8.7 Hz, 1H), 6.59 (s, 2H), 6.51 (d, J = 2.0 Hz, 1H), 4.55 (s, 1H). 13C-NMR 
(75 MHz, DMSO) δ 173.1, 158.0, 156.0, 155.0, 127.6, 126.9, 126.8, 126.1, 121.6, 








To a solution of 4-7 (0.154 g, 0.5 mmol) in DCM (20 ml) was added triethylamine 
(0.208 ml, 1.5 mmol) and trityl chloride (0.209 g, 0.75 mmol) at room temperature. 
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The reaction was stirred for 3 hrs. H2O (10 ml) was added to the reaction and stirred 
for 10 min, followed by phase separation. The aqueous layer was extracted once with 
DCM (10 ml). The combined organic phase was washed with H2O (10 ml), brine, 
dried over Na2SO4 and concentrated. The pure product 4-8 was isolated by silica gel 
chromatography (10-20% EtOAc/hexane) as a white solid (0.20 g, 73% over 2 steps) 
1H-NMR (300 MHz, CDCl3) δ 8.13 (d, J = 8.0 Hz, 1H), 7.92 (d, J = 8.9 Hz, 1H), 
7.36 – 7.15 (m, 18H), 6.54 (dd, J = 8.7, 2.1 Hz), 6.09 (d, J = 2.1 Hz, 1H), 5.78 (s, 1H), 
0.25 (s, 9H). 13C-NMR (75 MHz, CDCl3) δ 175.2, 157.5, 155.5, 152.4, 144.2, 129.0, 
128.3, 128.3, 127.4, 127.0, 126.7, 126.3, 121.8, 120.8, 114.2, 113.1, 103.7, 101.2, 






A solution of 4-8 (0.192 g, 0.35 mmol) in dry THF (10 ml) was added to o-
tolylmagnesium bromide (2.0 M in Et2O, 0.875 ml, 1.75 mmol) in dry THF (10 ml) 
under an argon atmosphere at room temperature. The reaction was then heated to 
50°C and stirred for 20 hrs, and quenched by the dropwise addition of H2O until gas 
evolution ceased. The solution was then acidified by 2N HCl to pH = 2. DCM was 
added and stirred for 5 min. The 2 phases were separated, the aqueous phase saturated 
with brine (10 ml) and extracted with DCM (4 × 10 ml). The combined organic phase 
was dried over Na2SO4, filtered and concentrated. This crude product was redissolved 
in DCM (7 ml). H2O (1 ml) and TFA (2 ml) were then added at room temperature. 
The reaction was stirred for 1 hr and quenched by the addition of H2O (5 ml). The 2 
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phases were separated and the aqueous phase saturated with brine (5 ml) and 
extracted with DCM (4 × 10 ml). The combined organic phase was washed once with 
NaHCO3 (10 ml), dried over Na2SO4, filtered and concentrated. The crude product 
was purified by a short silica gel column to yield 4-9 as an orange-red solid (73 mg, 
55% over 2 steps). 1H-NMR (300 MHz, DMSO) δ 9.84 (br s, 1H), 9.72 (br s, 1H), 
8.01 (d, J = 1.3 Hz, 1H), 7.63 – 7.49 (m, 4H), 7.32 (apparent d, 1H), 7.28 (d, J = 9.5 
Hz, 1H), 7.22 (d, J = 8.4 Hz, 1H), 7.20 (dd, J = 9.5, 1.8 Hz, 1H), 6.97 (d, J = 1.8 Hz, 
1H), 2.01 (s, 3H), 0.28 (s, 9H). 13C-NMR (75 MHz, DMSO) δ 163.6, 159.4, 156.6, 
152.9, 135.7, 133.6, 130.8, 130.7, 130.3, 129.4, 129.1, 126.2, 122.5, 120.8, 120.2, 





4-9 (73 mg, 0.19 mmol) was stirred in 1:1 1N NaOH/MeOH (8 ml) for 1 hr, then the 
pH of the solution was adjusted to pH = 2. DCM was added (20 ml) and the 2 phases 
were separated. The aqueous layer was saturated with brine (5 ml), and extracted with 
DCM (4 × 10 ml). The combined organic phase was dried over Na2SO4 and 
concentrated in vacuo. The crude product was purified by a short silica gel column to 
yield F as an orange-red solid (45 mg, 76%). 1H-NMR (300 MHz, MeOD) δ 7.96 (d, J 
= 1.3 Hz, 1H), 7.63 – 7.47 (m, 4H), 7.39 (d, J = 2.8 Hz, 1H), 7.35 (d, J = 1.8 Hz, 1H), 
7.30 (apparent d, J = 7.4 Hz, 1H), 7.14 (dd, J = 9.4, 2.1 Hz, 1H), 6.99 (d, J = 2.0 Hz, 
1H), 4.17 (s, 1H), 2.07 (s, 1H). 13C-NMR (75 MHz, MeOD) δ 165.7, 161.9, 160.1, 
154.9, 137.5, 135.0, 132.3, 132.2, 132.1, 131.8, 130.7, 130.6, 130.3, 127.5, 123.2, 
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122.3, 121.9, 121.6, 98.9, 86.3, 82.7, 19.7. HRMS calcd for [C22H16O1N1]+ : 310.1226, 
found 310.1239. 
 
5.2.3 Synthesis of Linkers 
 
HO OH HO OTBS










Scheme 5.1. Synthesis of linker 2-12 used in the preparation of SG2 
 
5-(tert-butyldimethylsilyloxy)pentan-1-ol2 (2-10) 
To a well-stirred solution of imidazole (6.80 g, 100.0 mmol) and 1,5-pentanediol 
(26.2 ml, 250 mmol) in dry DMF (200 ml) under nitrogen atmosphere was added a 
slurry of TBDMS-Cl (7.54 g, 50.0 mmol) in DMF (30 ml) dropwise over 30 min. The 
resulting mixture was stirred at room temperature overnight. DMF was removed in 
vacuo and H2O was added to the colorless oil residue and extracted twice with ether. 
The combined ether layers were washed with water, brine and dried over Na2SO4. 
After the removal of the solvent in vacuo, the crude product was purified by silica gel 
column chromatography (100% hexane – 20% EA/hexane) to give a slightly yellow 
oil (5.78 g, 53%) as the desired product. 1H-NMR (300 MHz, CDCl3) δ 3.65 – 3.59 (m, 
4H), 1.63 – 1.50 (m, 5H), 1.43 – 1.36 (m, 2H), 0.88 (s, 9H), 0.039 (s, 6H); ESI-MS: 
m/z [M+1]+ calcd: 219.2, found 219.0. 
 
5-(tert-butyldimethylsilyloxy)pentan-1-ol (2-11) 
To a solution of 2-10 (5.00 g, 22.9 mmol) and triethylamine (9.51 ml, 68.8 mmol) in 
DCM (100 ml) at 0°C was added p-toluenesulfonyl chloride (5.68 g, 29.8 mmol) in 
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small portions. The reaction was gradually raised to room temperature and stirred 
overnight. H2O was added and stirred for 5 min. The two layers were separated. The 
DCM layer was washed twice with saturated NaHCO3, water, brine and dried over 
Na2SO4. After the removal of the solvent in vacuo, the crude product was purified by 
silica gel chromatography to give a pale yellow oil (5.58 g, 78%).  1H-NMR (300 
MHz, CDCl3) δ 7.78 (d, J = 8.22 Hz, 2H), 7.33 (d, J = 8.22 Hz, 2H), 4.02 (t, J = 6.59 
Hz, 2H), 3.55 (t, J = 6.17 Hz, 2H), 2.44 (s, 3H), 1.70 – 1.61 (m, 2H), 1.48 – 1.32 (m, 
4H), 0.93 (s, 9H), 0.089 (s, 6H); ESI-MS: m/z [M+1]+ calcd: 373.2, found 373.0. 
 
tert-butyldimethylsilyl 5-iodopentyl ether3 (2-12) 
2-11 (5.5 g, 16.0 mmol) was added to a suspension of NaI (12.0 g, 80.1 mmol) in dry 
acetone (200 ml) at room temperature. The reaction mixture was stirred overnight. 
The white solid formed was filtered, and the filtrate concentrated. The oil residue was 
taken into ether and washed with saturated Na2SO3, H2O and brine, and dried over 
Na2SO4. The pure product (4.72 g, 90%) was obtained after concentration in vacuo. 
1H-NMR (300 MHz, CDCl3) δ 3.61 (t, J = 6.17 Hz, 2H), 3.19 (J = 6.99 Hz, 2H), 1.89 
– 1.80 (m, 2H), 1.57 – 1.41 (m, 4H), 0.89 (s, 9H), 0.05 (s, 6H). 
 
 
5.2.4 Synthesis of Azides 
 
Aromatic azides 
Aromatic azides except z4, z8 and z12 were previously prepared and reported by our 
group.5 Azides z4, z8 and z12 were prepared from the corresponding anilines 








1H-NMR (300 MHz, CDCl3) δ 6.97 – 6.88 (m, 4H), 3.87 – 3.84 (m, 2H), 3.13 – 3.10 







1H-NMR (300 MHz, CDCl3) δ 8.23 (dt, J = 9.2, 3.0, 2.2 Hz, 2H), 7.13 (dt, J = 9.1, 






1H-NMR (300 MHz, CDCl3) δ 7.21 – 7.18 (m, 2H), 8.87 (dd, J = 8.2, 2.3 Hz, 1H), 








1H-NMR (300 MHz, CDCl3) δ 8.61 (d, J = 2.6 Hz, 1H), 8.08 (d, J = 8.6 Hz, 1H), 
7.77 – 7.73 (m, 2H), 7.69 – 7.63 (m, 1H), 7.56 (dt, J = 8.4, 1.2 Hz, 1H). 13C-NMR (75 






1H-NMR (300 MHz, CDCl3) δ 8.90 (dd, J = 4.3, 1.7 Hz, 1H), 8.14 (dd, J = 8.4, 1.6 
Hz, 1H), 7.57 (dd, J = 8.2, 1.3 Hz, 1H), 7.50 (d, J = 7.4 Hz, 1H), 7.44 (dd, J = 8.4, 
4.3 Hz, 1H), 7.36 (dd, J = 7.4, 1.3 Hz, 1H). 13C-NMR (75 MHz, CDCl3) δ 149.4, 
137.2, 136.1, 129.3, 126.5, 124.1, 121.9, 118.2. 
 
Aliphatic azides 
Aliphatic azides z14, z16 and z17 were previously prepared and reported by our 






















To a solution of 2-hydroxymethyl-1,4-benzodioxane (0.166g, 1 mmol) in DCM (10 
ml) was added triethylamine (0.42 ml, 3 mmol) and cooled to 0°C. p-Toluenesulfonyl 
chloride (0.286 g, 1.5 mmol) was then added portionwise. The reaction was gradually 
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raised to room temperature and stirred overnight. Water (10 ml) was then added and 
stirred for 5 min. The two phases were separated and the aqueous phase extracted 
with DCM (10 ml). The combined organic phase was washed with saturated NaHCO3 
solution, brine, dried over Na2SO4 and concentrated. The crude product was purified 
by silica gel chromatography to yield the product as a white solid (0.256 g, 80%). 1H-
NMR (300 MHz, CDCl3) δ 7.80 (d, J = 8.3 Hz, 2H), 7.35 (d, J = 8.4 Hz, 2H), 6.87 – 
6.76 (m, 4H), 4.42 – 4.35 (m, 1.08), 4.28 – 4.16 (m, 3H), 4.03 (dd, J = 11.6, 6.3 Hz, 
1H), 1.64 (s, 3H). 13C-NMR (75 MHz, CDCl3) δ 145.2, 142.7, 142.2, 132.3, 130.0, 







To a solution of the tosylate (0.256 g, 0.8 mmol) in DMF (10 ml) was added NaN3 
(0.156 g, 2.4 mmol). The suspension was stirred at 65°C for 5 hrs and filtered. DMF 
was removed in vacuo and the residue was taken into ether and washed with water (2 
× 5 ml). The organic phase was washed with brine, dried over Na2SO4, filtered and 
concentrated to give a colorless oil as the pure product z15 (0.145 g, 95%). 1H-NMR 
(300 MHz, CDCl3) δ 6.94 - 6.84 (m, 4H), 4.38 – 4.31 (m, 1H), 4.25 (dd, J = 11.3, 2.4 
Hz, 1H), 4.06 (dd, J = 11.3, 6.7 Hz, 1H), 3.58 (dd, J = 13.1, 6.0 Hz, 1H), 3.49 (dd, J 
= 13.1, 5.2 Hz, 1H). 13C-NMR (75 MHz, CDCl3) δ 142.8, 142.4, 121.9, 121.9, 117.4, 







5.3 Solid-Phase Synthesis of Peptides and SG-Peptide Conjugates 
 
5.3.1 General Information 
 
All peptide synthesis described herein are carried out using standard Fmoc chemistry. 
HBTU, HOBt, and Fmoc-protected amino acids were purchased from GL Biochem 
(Shanghai, China). Fmoc-protecting amino acids with side chain protecting groups are 
listed here: Fmoc-Asp(OtBu)-OH, Fmoc-Glu(OtBu)-OH, Fmoc-His(Trt)-OH, Fmoc-
Lys(Boc)-OH, Fmoc-Asn(Trt)-OH, Fmoc-Gln(Trt)-OH, Fmoc-Arg(Pbf)-OH, Fmoc-
Thr(tBu)-OH, Fmoc-Tyr(tBu)-OH. MicroKansTM or MacroKansTM were used to 
contain the resin for the synthesis of individual peptide sequences. 
 
5.3.2 General Procedures 
 
General procedure for Fmoc deprotection 
The Fmoc-protected amino-functionalized resin or peptide chain was treated with 
20% piperidine/DMF for 45 min at room temperature. The resin was washed with 
DMF (3×), DCM (3×) and DMF (3×). 
 
General procedure for coupling of Fmoc-amino acids onto resin 
Fmoc-amino acid (4 equiv), HBTU (4 equiv) and HOBt (4 equiv) were dissolved in 
DMF (0.05 – 0.1 M) and DIEA (8 equiv) was added and agitated for 5 min. This pre-
activated Fmoc-amino acid solution was added to the resin and shaken for 3 h at room 




General procedure for the N-terminal capping of resin-bound peptides 
Following Fmoc deprotection of the last amino acid in the peptide sequence, the resin 
was washed in DMF (4×) and DCM (4×). The resin was resuspended in DCM, and 
DIEA (20 equiv) and acetic anhydride (10 equiv) were added sequentially. The resin 
was shaken for 3 h, then filtered and washed with DCM (4×) and dried thoroughly in 
vacuo.  
 
5.3.3 Synthesis of Ac-DEVD-SG1 
 
Loading of compound 2-7 onto 2-chlorotritylchloride resin 
Compound 2-7 (33 mg, 0.05 mmol) was dissolved in dry DCM (1.5 ml) and DIEA 
(35 µL, 0.2 mmol) was added. This solution was then added to 2-chlorotrityl chloride 
resin (50 mg, 0.025 mmol, loading ~0.5 mmol/g) previously swollen in dry DCM and 
shaken for 2 hrs at room temperature. The resin was filtered and washed thoroughly 
with DCM (5×) until the filtrate became colorless. The resin was then end-capped 
with MeOH for 1 hr. After filtration the resin was washed with DMF (3×), DCM (3×) 
and DMF (3×). 
 
Peptide synthesis 
Deprotection of resin-bound Fmoc-Asp-SG1 was carried out using the general 
procedure for Fmoc deprotection. The peptide chain was elongated using the general 
procedure for coupling amino acids onto the resin. Ac-Asp(OtBu)-OH was used 
instead of Fmoc-Asp(OtBu)-OH for the terminal residue. 
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Cleavage of peptide from resin 
After coupling Ac-Asp(OtBu)-OH onto the solid support, the resin was washed with 
DMF (3×), DCM (3×), MeOH (3×) and dried thoroughly under vacuum. A solution of 
TFA/TIS (95:5, 2 ml) was added to the resin at room temperature and shaken for 2.5 
hrs. The resin was filtered off and washed with DCM (2×). The combined DCM and 
cleavage solutions were concentrated to ~0.3 ml, then cold diethyl ether (3 ml) was 
added to precipitate the peptide. The peptide was then collected by centrifugation and 
washed with cold diethyl ether. This washing process was repeated for another time. 
The peptide thus obtained was dried in vacuo. 
 
5.3.4 Synthesis of SG2-Peptide Conjugates 
 
Synthesis of threonyl-glycyl resin (TG-resin) 
Fmoc-Gly-OH was loaded onto aminomethyl polystyrene resin (500 mg, loading 0.3-
0.8 mmol) previously swollen in DMF as described in the general procedure for 
coupling amino acids onto solid support. After the coupling reaction, the resin was 
filtered and washed with DMF (3×), DCM (3×) and DMF (3×). Fmoc deprotection 
was carried out also as described above. The resin was washed with DMF (3×), DCM 
(3×) and DMF (3×). The procedure was repeated with Fmoc-Thr(OtBu)-OH to give 
the O-protected TG-resin. Deprotection of the tert-butyl group was carried out with 
TFA/TIS (95:5) for 1 hr. The resin was subsequently washed with DCM (5×), then 
10% DIEA/DCM for 15 min, then with DMF (3×), THF (3×) and DCM (3×) and 
dried in vacuo to give the final TG-resin. 
 
Loading Fmoc-SG2-CHO onto TG-resin 
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Fmoc-SG2-CHO (3 eq) was dissolved in MeOH/DCM/DMF/AcOH (6:2:1:1, 3 ml) 
and added to the TG-resin (350 mg) and shaken for 5 hrs at room temperature. The 
resin was filtered and washed briefly with DCM (2×), then with DMF (3×), THF (3×), 
DCM (3×).  
 
Boc protection of secondary amine in oxazolidine moiety 
Boc2O (5 eq) was dissolved in DCM and added to the loaded resin and DIEA (2.5 eq) 
was added. The resin was shaken for 3 hrs, filtered and washed with DMF (3×), THF 
(3×), DCM (3×). The resin was then dried and swollen in DMF for 30 min before 
prior to coupling the first Fmoc amino acid. 
 
Peptide synthesis 
Fmoc amino acids were coupled sequentially onto the resin-bound SG2 using the 
general procedures for coupling and Fmoc deprotection. 30 mg of resin was used for 
each peptide. 
 
Side-chain deprotection and cleavage of peptides from resin 
The side chains and Boc-protected oxazolidines were deprotected by shaking the resin 
in TFA/TIS (95:5) for 45 min. For peptides containing the Arg(Pbf) residues, the 
deprotection cocktail used was TFA/TIS/H2O (95:4:1) and deprotection was carried 
out for 2 hrs. The resin was filtered and washed with DCM (5×). The peptides were 
released from the solid support by adding a mixture of DCM/MeOH/AcOH/H2O 
(12:5:2:1) to the resin and shaking for 15 min. This release procedure was repeated 
for another 2 times. The combined cleavage solutions containing individual peptides 
were concentrated and dried completely in vacuo for short and hydrophobic peptides 
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(sequences: FG, EY, AAF and AAL). For the rest of the peptides, the solutions were 
concentrated to ~ 300 µL and precipitated with 3 ml of cold ether. The peptides were 
then collected by centrifugation and dried in vacuo. 
 
5.3.5 Synthesis of Alkyne-Functionalized SG2-Based Substrates 
 
Reductive amination of PL-FMP resin with propargyl amine 
500 mg of the resin (0.45 mmol, loading = 0.9 mmol/g) was swollen in DMF for 1 hr. 
The resin was then filtered and resuspended in DMF/MeOH/AcOH (80:19:1, 8 ml). 
Propargyl amine was added (0.31 ml, 4.5 mmol), followed by NaBH3CN (301 mg, 4.5 
mmol). The suspension was agitated gently by magnetic stirring and heated at 55°C 
overnight. The resin was then filtered and washed with DMF (3×), MeOH (3×) and 
DCM (3×).  
 
Acylation with Fmoc-SG2-COCl 
The resin (500 mg, 0.45 mmol) was swollen in dry DCM, then filtered and 
resuspended in freshly distilled DCM. DIEA (0.78 ml, 4.5 mmol) was then added and 
the suspension was cooled to 0°C. Fmoc-SG2-COCl in dry DCM was then added 
dropwise with gentle stirring. The reaction was raised to RT and stirred overnight. 
The resin was filtered and washed with DCM (5×) followed by DMF (5×). The resin 
appears deep red in color. 
 
Peptide synthesis  
After Fmoc deprotection, peptide synthesis and N-terminal capping were carried out 




Prior to the final cleavage step, the resin was washed with 1% TFA/DCM for 0.5 hrs, 
then washed again with DCM (3×). The resin was then dried thoroughly in vacuo. 
Deprotection of the side chain protecting groups and cleavage from solid support was 
carried out with TFA/TIS/H2O (95:2.5:2.5). The solution was then concentrated to ~ 
300 µL and precipitated with 3 ml of cold ether. The peptides were then collected by 
centrifugation and dried in vacuo. 
 
5.3.6 Synthesis of Azido-Peptides and Control Peptides 
 
Loading Fmoc-AA-OH onto Rink Amide resin 
Rink amide resin (0.65 mmol, 1.3 g, loading = 0.5 mmol/g) was swollen in DMF (10 
ml) for 30 min. The resin was filtered and the Fmoc group was removed by shaking 
the resin 20% piperidine/DMF for 30 min, followed by washing with DMF (3×) and 
repeating the deprotection procedure for another 30 min. The resin was then filtered 
and washed with DMF (3×), DCM (3×) and DMF (3×).  
 
Peptide synthesis 
Sequential coupling of Fmoc-protected AAs onto the resin and Fmoc deprotection 
was carried out using the general procedures described in 5.3.2. When Fmoc-
Arg(Pbf)-OH is used as the AA, the coupling reaction was allowed to proceed for 14h 




N-terminal capping with 4-azidobutanoic acid 
After Fmoc deprotection of the final AA in the peptide (40 mg of resin), a pre-
activated solution of 4-azidobutanoic acid (4 equiv), HBTU (4 equiv), HOBt (4 equiv) 
and DIEA (8 equiv) in DMF (1 ml) was added to the resin and shaken for 3 h. The 
resin was filtered and washed with DMF (4×), DCM (4×) and dried in vacuo.  
 
N-terminal capping with Fmoc-SG2-COCl 
After Fmoc deprotection of the final AA in the peptide (40 mg of resin), the resin was 
washed with DMF (3×) and DCM (3×). The resin was then swollen in dry DCM for 
30 min, filtered and re-suspended in dry DCM and cooled to 0°C. DIEA (10 equiv) 
was then added. A solution of Fmoc-SG2-COCl in dry DCM was added dropwise to 
the resin and shaken at RT for 3 h. The resin was filtered and washed with  DCM (5×), 
DMF (3×) and DCM (3×). Prior to the final cleavage step, the resin was washed with 
1% TFA/DCM for 0.5 hrs, then washed again with DCM (3×). The resin was then 
dried thoroughly in vacuo. 
 
Cleavage 
Deprotection of the side chain protecting groups and cleavage from solid support was 
carried out with TFA/TIS/H2O (95:2.5:2.5). The solution was then concentrated to ~ 
300 µL and precipitated with 3 ml of cold ether. The peptides were then collected by 






5.4  Synthesis of Fluorophores Using “Click” Chemistry 
 
5.4.1  Microplate-Based Assembly of “Click” Fluorophore Library 
 
20 mM stock solutions of the alkynes and azides were prepared in DMSO. 40 
mM CuSO4 (50 mg in 5 ml) solution and 100 mM sodium ascorbate (99 mg in 5 ml) 
solution were prepared in H2O. tBuOH/H2O was first added to a 384-deep well 
microplate, followed by the alkyne (4 µL) and azide (10 µL). CuSO4 and sodium 
ascorbate solutions were mixed separately prior to the reaction and the mixture (8 µL) 
was added immediately to the solution of alkyne and azide in the microplate.  The 
plate was then sealed with a silicone cap-mat and shaken at room temperature. The 
volumes of each building block and reagent are summarized in the table below. The 
final concentrations of alkynes in the reaction are 2 mM for alkynes A-C and 1.33 
mM for alkynes D-F. 
 Stock concentration (mM) Vol. used (µL) Molar ratio 
Alkyne 20 4 1 
Azide 20 10 2.5 
CuSO4 40 4 2 
Sodium ascorbate 100 4 5 
3.75:1 tBuOH/H2O 
(for alkynes A-C) - 38 - 
1:1 tBuOH/H2O 
(for alkynes D-F) - 18 - 
 





For alkynes A-C: 
After shaking for 12 hrs, the solvent was removed in vacuo in a GeneVac HT-4X 
Series II parallel evaporation system. The ‘click’ product was re-suspended in 200 µL of 
DMSO (concentration ~ 400 µM) and used directly for LC-MS analysis. 
For alkynes D-F: 
After shaking for 12 hrs, 20 µL of each reaction solution was diluted to 100 µL in 
DMSO (concentration ~ 400 µM) and used directly for LC-MS analysis.  
 
 
5.4.2  Scale-up Synthesis of “Hit” Fluorophores 
Reaction set-up 
The alkyne (0.03 mmol) and azide (0.075 mmol) were dissolved in 
DMSO/tBuOH/H2O in a 15 ml centrifuge tube. CuSO4·5H2O (15 mg, 0.06 mmol) and 
sodium ascorbate (30 mg, 0.15 mmol) were dissolved in H2O (0.5 ml) and then added 
to the solution of the alkyne and azide. The tube was then shaken for 3 days for 
alkynes A-C, and 16 hrs for alkynes D-F. Reaction progress was monitored by LC-
MS. Due to difference in solubility of the alkynes, the amount and proportion of 
solvent for different alkynes varies. The table below summarizes the volumes of each 
solvent used. The final concentrations for the reaction are 8.6 mM for alkynes A-D 
and 10 mM for alkynes E-F. 
 
 Vol. of tBuOH (µL) Total vol. of H2O (µL) Vol. of DMSO (µL) 
Alkynes A-D 1500 1000 1000 
Alkynes E, F 1500 1500 0 
 
Table 5.2. Volumes of solvents used for scale-up ‘click’ chemistry 
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Work-up and purification 
i) “Click” products from alkynes A – C: product was precipitated by the addition of 
H2O (10 ml) and collected by centrifugation. The solid residue was dissolved in 
chloroform or DCM (10 ml), washed with H2O (2 × 5 ml) and dried over Na2SO4. 
The crude product was purified by silica gel chromatography (A-z9 and B-z15) or 
preparative HPLC (C-z17). A-z6 was purified by washing the crude product with 
acetonitrile twice. 
 
ii) “Click” products from alkynes D – F: DCM (10 ml) was added to the reaction 
mixture and washed with H2O (5 ml). The aqueous layer was saturated with brine and 
extracted with DCM (10 ml). The combined organic phase was dried over Na2SO4, 
filtered and concentrated. The crude product was purified by silica gel 










1H-NMR (300 MHz, CDCl3) δ 8.41 (d, J = 8.2 Hz, 1H), 8.41 (d, J = 2.6 Hz, 1H), 
8.27 (d, J = 8.9 Hz, 1H), 8.11 (d, J = 1.3 Hz, 1H), 8.07 – 8.00 (m, 1H), 7.84 (dd, J = 
8.2, 1.5 Hz, 1H), 7.16 – 7.11 (m, 2H), 6.97 (dd, J = 8.9, 2.3 Hz, 1H), 6.93 (d, J = 2.3 









1H-NMR (300 MHz, CDCl3) δ 8.40 (d, J = 8.2 Hz, 1H), 8.31 (s, 1H), 8.27 (d, J = 8.9 
Hz, 1H), 8.11 (d, J = 1.3 Hz, 1H), 8.02 (d, J = 2.1 Hz, 1H), 7.82 (dd, J = 8.4, 1.5 Hz, 
1H), 7.68 (dd, J = 8.2, 2.5 Hz, 1H), 7.43 (d, J = 8.0 Hz, 1H), 6.95 (dd, J = 8.7, 2.3 Hz, 
1H), 6.93 (d, J = 2.3 Hz, 1H), 3.96 (s, 3H), 2.50 (s, 3H). ESI-MS: m/z [M+1]+ calcd: 











1H-NMR (300 MHz, CDCl3) δ 8.34 (d, J = 8.2 Hz, 1H), 8.13 (d, J = 9.1 Hz, 1H), 
8.01 (s, 1H), 7.95 (d, J = 1.3 Hz, 1H), 7.71 (dd, J = 8.2, 1.5 Hz, 1H), 6.95 – 6.88 (m, 
4H), 6.70 (dd, J = 9.0, 2.5 Hz, 1H), 6.50 (d, J = 2.5 Hz, 1H), 4.81 – 4.70 (m, 2H), 
4.69 – 4.66 (m, 1H), 4.38 (dd, J = 11.7, 2.1 Hz, 1H), 3.96 (dd, J = 11.7, 5.8 Hz, 1H), 












1H-NMR (300 MHz, CDCl3) δ 8.74 (s, 1H), 8.29 (br s, 1H), 8.15 (d, J = 8.2 Hz, 1H), 
8.15 - 8.10 (m, 2H), 7.98 (apparent d, J = 7.6 Hz, 1H), 7.94 (apparent s, 1H), 7.87 – 
7.81 (m, 2H), 7.72 – 7.67 (m, 1H), 4.49 (t, J = 5.6 Hz, 1H). Note: triplet CH2 peak at 







1H-NMR (300 MHz, CDCl3) δ 8.33 (s, 1H), 7.98 (d, J = 1.5 Hz, 1H), 7.78 (dd, J = 
8.4, 1.7 Hz, 1H), 7.59 (apparent s, 1H), 7.50 – 7.38 (m, 4H), 7.29 (d, J = 8.2 Hz, 1H), 
7.21 (d, J = 7.6 Hz, 1H). 7.12 (d, J = 8.4 Hz, 1H), 6.98 (d, J = 9.7 Hz, 1H). 6.58 (dd, 
J = 9.7, 2.0 Hz, 1H), 6.48 (d, J = 1.8 Hz, 1H), 2.37 (s, 3H), 2.34 (s, 3H), 2.11 (s, 3H). 







1H-NMR (300 MHz, CDCl3) δ 9.63 (s, 1H), 8.36 (s, 1H), 8.12 (dd, J = 8.5, 1.6 Hz, 
1H), 7.77 (d, J = 2.1 Hz, 1H), 7.69 – 7.51 (m, 5H), 7.47 (d, J = 2.3 Hz, 1H), 7.43 (d, 
J= 8.6 Hz, 1H), 7.43 – 7.38 (m, 2H), 7.31 (d, J = 2.1 Hz, 1H), 7.24 (d, J = 9.9 Hz, 
1H), 3.88 (q, J = 6.7 Hz, 2H), 3.82 (q, J = 7.2 Hz, 2H), 2.36 (s, 3H), 2.32 (s, 3H), 
1.33 (t, J = 7.0 Hz, 3H), 1.26 (t, J = 7.2 Hz, 3H). HRMS calcd for [C34H33O1N4]+ : 







1H-NMR (300 MHz, CDCl3) δ 9.90 (s, 1H), 9.57 (br s, 1H), 9.51 (br s, 1H), 9.01 (d, J 
= 2.3 Hz, 1H), 8.46 (s, 1H), 8.21 – 8.14 (m, 3H), 7.93 – 7.87 (m, 1H), 7.78 (apparent t, 
J = 7.71 Hz, 1H), 7.64 – 7.51 (m, 4 H), 7.45 (d, J = 8.6 Hz, 1H), 7.38 (d, J = 7.4 Hz, 
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1H), 7.30 (d, J = 9.5 Hz, 1H), 7.19 (dd, J = 9.4, 1.7 Hz, 1H), 7.00 (d, J = 1.8 Hz, 1H), 









1H-NMR (300 MHz, CDCl3) δ 9.47 (br s, 1H), 9.41 (br s, 1H), 8.88 (s, 1H), 8.33 (s, 
1H), 8.26 (s, 1H), 8.18 – 7.94 (m, 3H), 7.70 – 7.49 (m, 3H), 7.36 (d, 8.4 Hz, 1H), 7.28 
(d, J = 2.3 Hz, 1H), 7.18 (apparent d, J = 9.5 Hz, 1H), 7.11 (s, 1H), 6.99 (br s, 1H), 
6.94 (s, 1H), 4.52 (t, 5.6 Hz, 1H), 3.5 (m, 2H), 2.07 (m, 3H). HRMS calcd for 
[C31H26O5N5S1]+ : 580.1649, found 580.1662. 
 
5.5 Spectroscopic Analysis 
 
5.5.1 General Information 
 
Fluorescence measurements were recorded on a Perkin Elmer LS55 fluorescence 
spectrometer. Absorbance data were recorded on a Shimadzu UV-2450 spectrometer. 
Samples were prepared as 10 mM stock solutions in DMSO and diluted in the 
appropriate solvents for analysis. 
 
5.5.2 Determination of Molar Extinction Coefficients and Quantum Yields 
 
UV absorption and integrated fluorescence emission for SG1 was determined in 
EtOH with sample concentrations ranging from 0.4 to 1.6 µM, with excitation 
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wavelength at 493 nm. Fluorescein (Φst = 0.95) in 0.1 N NaOH was used as standard, 
with excitation at 496 nm. UV absorption and integrated fluorescence emission was 
determined in DMSO for A, Az-6, Az-9, B, B-z15, C and C-z17, and in EtOH for D, 
D-z2, E, E-z2, F, F-z12 and F-z17. Rhodamine 6G (Φst = 0.95, excitation wavelength 
= 488 nm) in H2O and Coumarin 1 (Φst = 0.73, excitation wavelength = 360 nm) were 
used as standards for alkynes D-F and alkynes A-C respectively. 
 
Relative fluorescence quantum yield was determined using the following equation: 
Φx = Φst(mx/mst)(ηx2/ηst2) 
Where  Φx, Φst = quantum yield of SG1 and fluorescein respectively 
 mx, mst is the slope of best linear fit from the plot of integrated fluorescence 
intensity against absorbance (at 493 nm for SG1, 496 nm for fluorescein) 
 η = refractive index of solvent used (η = 1.333 for H2O, η = 1.334 for 0.1 N 
NaOH, η = 1.361 for EtOH at 25°C, η = 1.479 for DMSO at 20°C) 
 
 
5.6 Microplate-Based Fluorescence Assays 
 
5.6.1 General Information 
 
Serine proteases trypsin (Cat# 93610, Fluka), α-chymotrypsin (Cat# C-4129, Sigma), 
β-chymotrypsin (Cat# C-4629, Sigma) and subtilisin (Cat# 85968, Fluka) and 
thrombin Cat# (T-3399, Sigma) were purchased from commercial sources. Cysteine 
proteases caspase-3 and caspase-7 were recombinantly expressed as previously 
describedi.  
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5.6.2 Enzymatic Assays with SG-Peptide Conjugates 
 
Cleavage of the peptide substrates by selected enzymes were monitored in black flat-
bottom polypropylene 384-well plates (Nunc, USA) using 25 µL volume for each 
reaction. 20 µΜ of substrate and 0.125 U of each enzyme were used for each assay. 
Enzymatic cleavage of the substrates was monitored by fluorescence increase 
(excitation and emission wavelengths at 485 nm and 520 nm respectively) with a 
SynergyTM 2 multi-mode microplate reader (Biotek Instruments). 
 
5.6.3 Fluorescence Analysis of “Click” Fluorophore Library 
 
The 400 µM DMSO solution of the crude product from the click chemistry reaction 
used for LC-MS analysis was further diluted to 20 µM in 4 different solvents (40% 
DMSO/H2O, DMSO, EtOH and DCE) for preliminary examination of fluorescence 
properties in microplate format. Fluorescence spectra of each reaction product were 
obtained in black flat-bottom polypropylene 384-well plates (Nunc, USA) using a 
volume of 40 µL for each click product with a SynergyTM 2 multi-mode microplate 
reader (Biotek Instruments).  The solvent used for each fluorophore is the solvent in 








5.7 Microarray Experiments 
 
Preparation of slides 
Amine-functionalized glass slides were prepared as previously described6. The N-
phthalimide-protected alkoxyamine linker 15 (85 mM) was pre-activated with HBTU 
(128 mM) and DIEA (170 mM) in DMF for 5 min and the slides were incubated with 
this solution for 2-3 hrs. The slides were then rinsed with DMF, then ethanol and 
dried under a stream of nitrogen. Deprotection of the phthalimide group was then 
carried out by incubating the slides with 3% hydrazine/DMF for 3 hrs. Slides were 
then rinsed with ethanol and air-dried. These alkoxyamine-functionalized slides may 
be stored at room temperature until the time of usage. 
 
Microarray preparation and reactions 
Peptides were diluted to a final concentration of 0.25 mM in 16 µL 1:1 
DMSO/spotting buffer (250 mM NaOAc, 300 mM NaCl, pH 5) and distributed in a 
384-well plate. The peptides were spotted onto the alkoxyamine-functionalized slides 
with an ESI SMA arrayer (Ontario, Canada) with the printhead installed with Stealth 
SMP15B Microspotting pins (Telechem, U.S.A.). Spots generated were of 
approximately 350 µm diameter and were printed with a spot to spot spacing of 750 
µm. The pins were rinsed in between samples using two cycles of wash (for 10 s) and 
sonication (for 10 s) in reservoirs containing 70% ethanol followed by drying under 
reduced pressure (for 10 s). The slides were allowed to stand for 3 h on the printer 




Stock solutions of the proteases were prepared in appropriate buffers according to the 
table below. Enzymatic reactions were initiated by applying the enzyme solution onto 
the slides. To halt the reaction, slides were dipped in water for 2 min, rinsed with 
ethanol and air-dried. 
 
Protease Concentration Buffer 
Papain 0.01U/µL Tris.HCl, pH 8 
Chymopapain 0.01U/µL PBS, pH 7.4 
α-Chymotrypsin 0.01U/µL PBS, pH 7.4 
β-Chymotrypsin 0.01U/µL PBS, pH 7.4 
Trypsin 0.01U/µL PBS, pH 7.4 
Thrombin 0.01U/µL PBS, pH 7.4 
Subtilisin 0.01U/µL PBS, pH 7.4 
Caspase-3 20 nM Caspase-3/7 assay buffer 
Caspase-7 20 nM Caspase-3/7 assay buffer 
 
Table 5.3. Concentrations and buffers for proteases used in microarray experiments. 
Caspase-3/7 assay buffer consists of 20 mM PIPES, 100 mM NaCl, 10 mM DTT, 1 mM EDTA, 
0.1% w/v CHAPS, 25% w/v sucrose, pH 7.2. 
 
Spotting pattern for fingerprint and kinetic experiments 
 
Figure S1. Spotting pattern used in each sub-grid in A) fingerprint experiments and B) kinetic analysis 










































Kinetic analysis of peptide cleavage from microarray and microplate experiments 
Time-dependent experiments on the microarray was carried out with various enzymes 
and peptides using an enzyme concentration of 0.01 U/µL (total volume = 20 µL for 
each sub-grid in Figure S1). Fluorescence data was taken at various time points and 
quantified. To obtain kinetic data, the data was fitted to the following equation: 
∆RF = RFinit × [1-exp(-kobs × time)] 
Where kobs = (kcat/Km)*E, representing the observed kcat/Km under a given enzyme 
concentration E, and ∆RF is the change in fluorescence intensity (RF – RFinit). 
For microplate-based kinetic experiments, 0.125 U of the enzyme was incubated with 
20 µM of peptide and the fluorescence intensity was taken at various time points. The 






5.8.1 General Information 
 
Images were captured using an Olympus IX71 inverted microscope, equipped 
with a 60X oil objective (NA 1.4, WD 0.13 mm) and CoolSNAP HQ CCD camera 
(Roper Scientific, Tucson, AZ, USA). Images were processed with MetaMorph 
software (version 7.1.2.; Molecular Devices, PA, USA). The filter sets used for the 
different fluorophores were as follows: SG1/SG2: Ex 460– 480HQ, dichroic DM485, 
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Em 495–540HQ; TMR-dextran: Ex BP535–555HQ, dichroic DM565, Em 570–
625HQ. 
 
5.8.2 Apoptosis imaging in live cells with Ac-DEVD-SG1 
 
The human carcinoma epithelial carcinoma cell line HeLa was cultured in growth 
media (DMEM) supplemented with 10% fetal bovine serum, penicillin and 
streptomycin). Cells were maintained in a humidified atmosphere of 5% CO2 at 37 °C.  
Cells were seeded on glass-bottom dishes (Mattek, USA) and grown to 70% 
confluence. Before microinjection, the growth media was replaced with phenol-red 
free media (Invitrogen). TMR-dextran (Invitrogen, D-1819) was co-injected with 50 
µM of Ac-DEVD-SG1 into the cells as a marker. All injections were performed using 
Eppendorf InjectMan® NI 2 (injection pressure = 25 hPa, compensation pressure = 13 
hPa, injection time = 0.2s). To induce apoptosis, cells were incubated with 1.0 µM of 
staurosporine for 1 hr and imaged. 
 
5.8.3 Evaluating the subcellular locations of the localization peptides† 
 
The human carcinoma epithelial carcinoma cell line HeLa and the human breast 
adenocarcinoma cell line MCF7 were cultured in growth media (DMEM) 
supplemented with 10% fetal bovine serum, penicillin and streptomycin). Cells were 
maintained in a humidified atmosphere of 5% CO2 at 37 °C.  
Cells were seeded on glass-bottom 24-well plates (Mattek, USA) and grown to 80% 
confluence. Prior to incubation with the peptides, the growth media was removed and 
                                               †
 Work done in collaboration with Candy Lu H. S. 
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replaced with serum-free phenol red-free media. The peptides were added to 
individual wells to a final concentration of ~10 µM (1% DMSO). The cells were then 
incubated with the peptides for 1 h and rinsed briefly with PBS, and resuspended in 
serum-free media. The corresponding organelle trackers were added to each well at a 
concentration of 2 µ/ml and incubated for 15 min before rinsing and reconstitution in 
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